Skip to main content
Register
Mobile App
Browse Schedule
Full Schedule
Browse by Track
Browse by Session Type
Keyword Search
Browse by Poster Abstract
Browse by Poster Number
Browse by Poster Title
Browse by Presenter
Browse by Track
Browse by SubTrack
Solution Center
Browse by Company
Browse by Track
Browse by Booth Number
Floorplan
Visit The Solution Center
Networking Activities
Healthy Start
Philanthropy
Reception
Affiliate Event
Community Social
People
Speakers
Attendees
Sponsors
Hotels
Conference Proceedings
Login required
My Schedule
Login required
Evaluation/Surveys
Login required
Login
Toggle navigation
Home
Register
Mobile App
Browse Schedule
Full Schedule
Browse by Track
Browse by Session Type
Keyword Search
Browse by Poster Abstract
Browse by Poster Number
Browse by Poster Title
Browse by Presenter
Browse by Track
Browse by SubTrack
Solution Center
Browse by Company
Browse by Track
Browse by Booth Number
Floorplan
Visit The Solution Center
Networking Activities
Healthy Start
Philanthropy
Reception
Affiliate Event
Community Social
People
Speakers
Attendees
Sponsors
Hotels
Conference Proceedings
Login required
My Schedule
Login required
Evaluation/Surveys
Login required
Conference Brochure
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Preclinical Development
Bioanalytics
Clinical Pharmacology
Manufacturing and
Bioprocessing
Formulation and Quality
Events Networking
Partner Presentation-
Bioanalytics
Partner Presentation-
Clinical Pharmacology
Partner Presentation-
Formulation
Partner Presentation-
Preclinical
Rapid Fire Bioanalytics
Rapid Fire Clinical
Pharmacology
Rapid Fire Formulation
Rapid Fire Manufacturing &
Bioprocessing
Rapid Fire Preclinical
Browse by Poster Track
Browse by Poster Track
Type here to filter the list
Bioanalytics
W1030-04-028 - A Platform Technology For The Rapid Generation Of Robust Anti-Idiotypic Binders For Clinical PK Assays
Favorite
W1130-04-028 - A Diagnostic Tool for Red Blood Cell Disorders - Chipcytometry as a New RBC Analysis Platform
Favorite
M1130-04-025 - A Fit for Purpose Validation of a Single Plate Assay for the Quantification of Total and Bound Cytokine
Favorite
T1030-03-021 - A Gyros Multiplex Bioanalytical Strategy for Monitoring a Fusion Fc-Peptide Biotransformation In Vivo
Favorite
M0930-03-021 - A Hybrid IC-LC-MS/MS Approach to the Quantification of CD154 from Plasma
Favorite
T0930-03-017 - A Hybrid LBA/LC-MS Assay for Multiplex Quantitation of Insulin Analogs in Plasma
Favorite
T1330-04-025 - A LC-MS/MS Method for Quantitation of Temozolomide in Mice Brain following Intra Cerebral Brain Micro-dialysis
Favorite
T1030-04-029 - A Middle-Down Analytical Strategy for Determination of Mature Growth Differentiation Factor-15 (GDF-15) in Human Serum Using Immunoaffinity Enrichment – Liquid Chromatography/Tandem Mass Spectrometry
Favorite
T0930-03-021 - A Multiplex Bead-Based Immunoassay (Luminex) for the Analysis of Inflammatory Cytokines in Mouse Serum
Favorite
M0930-04-027 - A New Immunoaffinity Extraction Method for Rapid Diagnosis of Paralytic Shellfish Poisoning in Humans
Favorite
M1230-03-020 - A Novel and Sensitive UPLC-MS/MS Method for the Determination of Mequitazine in Rat Plasma and Urine
Favorite
M1130-03-020 - A Novel Immunoassay for Assessment of Specific Anti-Drug IgE Antibodies
Favorite
M1330-03-023 - A Novel Lispro ELISA for Specific Determination of the Rapid-Acting Insulin Analog, Insulin Lispro, in Human Samples
Favorite
M1130-03-017 - A Novel Robust Approach to Detect Treatment-Boosted Anti-Drug Antibodies (ADA) in a Study Population with Pre-Existing ADA
Favorite
T1430-04-028 - A pH-sensitive Liposome Approach to Target the Survivin Protein: Overcoming Cancer Chemoresistance in Retinoblastoma
Favorite
T1330-03-018 - A Rapid and Selective Method for 5-Azacytidine in Rat Plasma, Lung, Brain, and Liver Using LC-MS/MS
Favorite
M1430-03-022 - A Sensitive Enantioselective LC-MS/MS Method for the Determination of Dasotraline in Human Plasma and Its Application to Clinical Development
Favorite
W1130-03-020 - A Sensitive Liquid Chromatography-Mass Spectrometry Method for Detection of Usnic Acid in Rat Plasma and Its Application to Pharmacokinetic Study of Transdermal Administration
Favorite
M1530-03-017 - A Sensitive Microflow LC/MS/MS Method for the Analysis of Fluticasone Propionate in Human Plasma
Favorite
M1330-04-028 - A Simplified and Automated LC-MS/MS Method to Determine of 25-OH-Vitamin D2/D3 in Human Serum Using Strata RP Online Extraction Column
Favorite
W1130-03-021 - A Targeting Theranostics Nanomedicine for Real-Time Monitoring Drug-Release
Favorite
T1330-03-017 - A UPLC-MS/MS Method for the Simultaneous Determination of Diethyl Phthalate and Its Metabolite, Monoethyl Phthalate, in Rat Plasma, Urine, and Various Tissues Collected from a Toxicokinetic Study
Favorite
M1330-03-017 - Absolute Quantitation of Biotherapeutic Drug Product and Endogenous Protein in Human Serum Using a Hybrid Immunoassay-LC/MS Approach
Favorite
T0930-04-029 - Absolute Quantitation of Five Antibody Drug Products in Dosed Monkey Serum, CSF and Brain Lysate for Lead Candidate Identification Using LC-MRM/MS
Favorite
T0930-03-018 - ADC PK Profiling Strategies on LC-MS Platforms: Top-Down, Bottom-Up, and Multiplexing
Favorite
M1530-03-020 - Advances in Approval of Topical Dermatological Generic Drug Products Pertinence of New FDA Drafted Guidance on Acyclovir Cream-IVRT/IVPT
Favorite
W0930-03-020 - Aegyris™ – The Simple and Efficient Software Solution for the Validation of Immunogenicity Assays to Support Vaccine Clinical Trials
Favorite
W1130-04-025 - An LC-MRM/MS-Based PD Assay for Monitoring Site Occupancy of an Oncogene Protein in Tumor Xenograft Tissue from Mice Dosed with Alkylating Agent
Favorite
T1030-04-028 - Analysis of Anamorelin Stereoisomers in Human Plasma Using Coupled Achiral / Chiral HPLC with Tandem Mass Spectroscopy Detection
Favorite
M1330-04-027 - Analysis of Arachidonic Acid as a Biomarker in Human Plasma Using LC-MS/MS for Clinical Studies
Favorite
W1230-04-025 - Analytical Challenges in Quantitation of Nanoparticle Encapsulated Material
Favorite
T1030-04-026 - Analytical Comparability Strategies for Rituximab and Its Biosimilar
Favorite
W1230-03-021 - Analytical Method for the Quantification of Magnesium Ascorbyl Phosphate (MAP) in Isotonic Normal Saline with Ion-Pair Chromatography
Favorite
W0930-03-018 - Anti-Drug Antibody Data Management Using E-Workbook
Favorite
T0930-04-028 - Application of Multivariate Analysis of FTIR and CD Spectroscopy Data to Differentiates Structural Perturbations in Proteins
Favorite
W0930-04-025 - Application of Taylor Dispersion to the Particle Size Characterization of mRNA and mRNA-loaded Lipid Nanoparticles
Favorite
T1530-04-025 - Application of the Multi-Attribute Method (MAM) in Lot-to-Lot Comparison of Rituximab Drug Product
Favorite
M1430-04-026 - Assessing the Predictive Response of a Simple and Sensitive Blood-Based Biomarker between Estrogen-Negative Solid Tumors
Favorite
M1130-04-027 - Association of Salivary Biomarkers with Skeletal Maturation in Orthodontic Patients
Favorite
M1130-04-029 - Automated Analysis of Melanoma Gene Expression Patterns by Sequential Interrogation of Variable RNA Average Count-space
Favorite
W1230-03-017 - Automated High-Throughput Sample Preparation of Insulin-Like Growth Factor 1 for Targeted LC-MS/MS Quantification
Favorite
T1430-04-027 - Bacteria and Human Cells-Mediated Synthesis of Biogenic Metallic Nanoparticles. A Nanometric Trojan Horse Approach
Favorite
M1330-04-029 - Bioanalysis of Plasma Amino Acids as Potential Biomarkers of NSAIDs-Induced Gastric Injury by Liquid Chromatography-Tandem Mass Spectrometry
Favorite
T1030-04-027 - Cannabis for Medical Purposes: Simultaneous Quantification of 11 Cannabinoids in Cannabis by UPLC-UV
Favorite
M1430-03-020 - Case Study to Address Matrix Interference in a PK Assay: Serum versus Plasma
Favorite
T1530-03-020 - Challenges of Cross-Lab Validation for Sphingolipids Biomarker Assays with Multiple Isomers in Human Dried Blood Spots
Favorite
W1030-03-017 - Characterization of Exosomes Derived from Cancer Resistant Cells as a Drug Delivery Carrier
Favorite
M1530-04-028 - Characterization of Two Kinase-Modulating Compounds in Tumor Infiltrating Lymphocytes (TILs) Using Flow Cytometry and Meso Scale Discovery
Favorite
M1030-03-019 - Co-delivery of Doxorubicin and Erlotinib by Dual Functionalized Liposomes on Glioblastoma Tumor Regression Using an In Vitro Brain Tumor Model
Favorite
T1430-03-020 - Comparability, Similarity, Linearity and High Order Structure Analysis of an IgG1 Sample by Microfluidic Modulation Spectroscopy
Favorite
M1130-03-018 - Controlling Effects of IgG4 Hybrid Antibody Formation in Bridging Immunogenicity Assays
Favorite
M1030-04-029 - Detection and Identification of New Protein Features Using Multi-attribute Monitoring (MAM) as Part of Mass Spectrometry-Based Quality Control (QC)
Favorite
M0930-04-026 - Determination of Triazolam and Its Two Major Metabolites in Mouse In Vivo Using SFC Coupled with Mass Spectrometry
Favorite
T1430-04-026 - Developing and Qualifying the Anti-drug Antibody (ADA) Assay for a Bispecific Nanobody by Electrochemiluminescence (ECL) Immunoassay
Favorite
W1030-03-018 - Development and Assessment of Novel Fluorescent Hyaluronic Acid Nano-Particulate System for Biomedical Applications in Bio-Imaging, Drug Delivery, and Bio-Sensing
Favorite
W1030-04-029 - Development and Characterization of Mouse Th17-Related and Cytokine Multiplex V-PLEX® Assays
Favorite
T1530-04-029 - Development and Implementation of a Rapid Generic Ig Dip and Read Ligand Binding Assay Format on the Octet RED 384™ for the Quantitation of Human IgG in Mouse Plasma
Favorite
M0930-04-030 - Development and Optimization of a Liquid Chromatography Tandem Mass Spectrometry Method for Quantification of Bevacizumab and Ranibizumab in Human Plasma after Intravitreal Administration
Favorite
M1030-03-022 - Development and Proof-of-Concept of a New Flow-through System for High Resolution NMR to Evaluate Biologics-Producing Cell Lines and Their Growth Environments
Favorite
T1530-03-019 - Development and Validation of a Human Total Soluble OX40 Biomarker Assay for use on Clinical Studies
Favorite
W1130-03-022 - Development and Validation of a LC-MS/MS Method for the Determination of Perampanel in Human Plasma
Favorite
W1130-03-019 - Development and Validation of a UPLC-MS/MS Method and Comparison with an HPLC-UV Method for Simultaneous Determination of cis-, trans-cefprozil Isomer in Human Plasma
Favorite
T1230-03-019 - Development and Validation of an ELISA Method for the Determination of Anti-Polyethylene Glycol (PEG) Antibodies in Human Serum
Favorite
M1430-03-019 - Development and Validation of an Immunoassay for Total Therapeutic Antibody (RO7112689; SKY59) Quantification in the Presence of C5 and that for Total C5 Quantification in Cynomolgus Monkey Plasma
Favorite
M1330-03-019 - Development and Validation of LC-MS/MS Assay for 5-Amino-1-Methyl Quinolinium in Rat Plasma
Favorite
M1230-03-018 - Development and Validation of LC-MS/MS Assay for Simultaneous Analysis of Simvastatin, Atorvastatin, Rosuvastatin and Their Active Metabolites in Plasma of Obese Subjects Underwent Bariatric Surgery
Favorite
M0930-03-022 - Development and Validation of Robust Analytical Method to Quantify rhSOD3 from Mouse Plasma via HPLC-MS/MS
Favorite
T1330-04-027 - Development of a Simple and Sensitive LC-MS/MS Method for the Determination of Tramadol and Its Metabolites in Human Plasma
Favorite
T1130-04-025 - Development of a Ultra-Sensitive Digital Immunoassay for Human Soluble HLA-E Biomarker
Favorite
M1130-03-022 - Development of an Anti-Drug Antibody Assay with High Drug Tolerance for Bevacizumab (Avastin®) and Its Biosimilars
Favorite
T1030-03-019 - Development of an HPLC Method for Simultaneous Detection of Pterostilbene and Its Metabolites
Favorite
M0930-03-018 - Development of an Immunoaffinity-LC-MS/MS Bioanalytical Method for the Highly Sensitive Quantification of Active Infliximab and Adalimumab
Favorite
T1330-03-021 - Development of an LC-MS/MS Method for Determining Methylsulfonylmethane (MSM) Pharmacokinetics in Humans
Favorite
M1430-03-017 - Development of an LC-MS/MS Method for Quantification of Cytarabine in Rat Plasma
Favorite
W1230-03-018 - Development of an Ultra-Sensitive Biomarker Assay for Megakaryocyte Potentiating Factor
Favorite
M1030-03-017 - Development of Antibodies and PK and ADA Assays for a Cysteine Knot Fusion Protein
Favorite
M1430-03-024 - Development of High Sensitivity and Specificity LC-MS/MS Method to Evaluate Peptide Permeability across Cell Monolayer
Favorite
T0930-03-022 - Development of NISTmAb-derived homogeneous antibody-drug conjugate (ADC) standards
Favorite
M0930-04-029 - Development of Novel Mass Spectrometry Methods for the Determination of Drug to Antibody Ratio of Interchain Cysteine Linked Antibody Drug Conjugates(ADC)
Favorite
M1330-03-024 - Diagnosing and Solving Phospholipid-Based Matrix Effects in LC-MS Bioanalysis
Favorite
T1030-03-017 - Discovery of Antibacterial Properties of Pyrimidine Derivatives by High Throughput Screening of Pre-metabolized Chemical Library
Favorite
T1130-03-018 - Dual Functionalized Liposomes for Co-delivery of Anti-cancer Chemotherapeutics to Brain Tumor
Favorite
T1130-04-030 - Echinacea purpurea as an Herbal Adjuvant for Vaccine-Based Cancer Therapy
Favorite
T1230-03-021 - Effector and Regulatory T Cell Epitope Content, and not Humanization nor Biophysical Properties, is Predictive of Antibody Immunogenicity
Favorite
M1430-03-023 - Efficient and Economical Preclinical Pharmacokinetic Analyses for Human Therapeutic Antibodies and Constructs, Using a Validated Human Immunoglobulin Immunoassay in Plasma of Mice, Rats, and Monkeys
Favorite
T1230-04-025 - EGFR Transactivation by Endothelin Receptor Involves a Src Activated Pro-HBEGF Cleavage in Asthmatic Airway Smooth Muscle (ASM) Cells
Favorite
T1130-04-031 - Enhancing the Antitumor Activity of Adenovirus Vaccines by Combining with Intratumoral Delivery of CpG-loaded Nanoparticles.
Favorite
M1030-04-028 - Evaluating Platelet Reactivity via Laser Defraction Particle Analysis
Favorite
M1430-03-018 - Evaluation of an ELISA Method Using Novel Amplification Reagent and Its Comparison with Traditional Colorimetric ELISA Assay for the Measurement of Aflibercept in Biological Matrices
Favorite
W0930-04-027 - Evaluation of Generic PK Assay: Comparison between ELISA and Ella Platform
Favorite
T1430-04-025 - Evaluation of the Subcellular Uptake and Distribution of Gemini Surfactant Gene Delivery Nanoparticles Using Mass Spectrometry
Favorite
W1130-04-026 - Fit-for-Purpose GLP Validation of an Intra-Cellular Cytokine Staining Assay
Favorite
T1230-04-029 - Fit-for-Purpose Validation for the Measurement of 29 Cytokines in Human Plasma by MesoScale
Favorite
W0930-04-029 - Functional Bioassay Miniaturization is Enhanced by Using Acoustic Liquid Handling for Antibody Transfer
Favorite
M1430-04-027 - Galactose Single Point Test as a Safe, Simple, Highly-Sensitive Quantitative Liver Function Assessment in Patients with Non-alcoholic Fatty Liver Disease
Favorite
T1230-04-028 - Glycogen Synthase as Biomarker for Neurodegenerative Lafora Disease
Favorite
W1230-04-026 - Green Synthesis of a Synergetic Structure of Tellurium Nanowires and Metallic Nanoparticles for Biomedical Applications
Favorite
T1230-03-022 - HLA DR-binding Assays as a Tool for Immunogenicity Screening: Developing the Best Practices for Determining Immunogenicity
Favorite
T1530-04-027 - How Does Hydroxypropyl-ß-cyclodextrins Inhibit Human Growth Hormone Aggregation?
Favorite
W1230-03-019 - HSP47 Immunoassay Validation and Application to Analysis of Normal and Disease Samples
Favorite
T1130-04-026 - Image Cytometry: A New Method for Deep Phenotyping of Rare Cells in the Blood of Oncology Patients
Favorite
W0930-03-017 - Impact of Critical Reagents Characterization and Handling on Anti-Drug Antibodies (ADA) Assay Method Development: A Case Study for a Humanized Monoclonal IgG ADA Assay
Favorite
W1030-03-022 - Improved Acceptance Criteria for Laboratory Developed Flow Cytometry Tests
Favorite
T1530-03-017 - Improved Sample Processing to Optimize Stability for Total Glutathione Determination in Human Plasma Using a Fit-for-Purpose Approach
Favorite
T1230-03-020 - Improving Drug Tolerance by Going Back to the Basics
Favorite
T1030-03-020 - In Vivo Assessment of Multiple Quality Attributes of Protein Therapeutics and Their Biological Relevance by High Resolution Liquid Chromatography Mass Spectrometry and Multiplexed Proteomics Approach
Favorite
T0930-04-027 - Influence of Chitosan Coating on the Oral Bioavailability of Gold Nanoparticles in Rats
Favorite
T0930-03-020 - Inhibition on Esterase Mediated Hydrolysis of Simvastatin in Rat Blood and the Impact on iIs Pharmacokinetics in Rats
Favorite
T1330-03-019 - LC/MS/MS Method for the Quantification of Metronidazole in Skin Dialysate
Favorite
W1130-03-017 - LC-MS Method Development of Midazolam and Ketamine: Application to a Pharmacokinetic Study in Patients on Extracorporeal Membrane Oxygenation Therapy
Favorite
M1430-04-025 - LC-MS/MS Method for Quantitative Tissue Distribution Analysis (QTDA) of Targeted Metabolomics
Favorite
M1130-04-026 - LC-MS/MS Method for the Quantification of 3,4-Dihydroxyphenylglycol (DHPG), a Biomarker for MAO-A Inhibition
Favorite
M1330-04-025 - LC-MS/MS Method for the Quantification of OAT1 Biomarkers
Favorite
M1230-04-025 - Liver metabolomics in Mice with Erythropoietic Protoporphyria
Favorite
W1030-03-021 - Lot-to-lot Comparison and Long-term Stability of the IDS-iSYS Growth Hormone and Insulin-like Growth Factor-1 Immunoassays for Clinical Trial Support
Favorite
T1130-04-027 - Measurement of Protein X by LC-MRM/MS Using the AQUA Approach in Dissected FFPE Breast and Gastric Tumor Tissue
Favorite
M1330-03-018 - Measurement of Squalene in Human Plasma by UPLC-APCI-MS/MS
Favorite
T1030-03-018 - Metabolite Profiling of Ceftibuten and Clavulanate following Individual and Combined Oral Administration to Healthy Subjects to Evaluate Potential for Drug-Drug Interaction
Favorite
T1330-04-029 - Method Development for Bioanalysis of Efavirenz using HPLC-MS
Favorite
T1130-03-022 - Method Performance Assessment during Clinical Development to Support Robust Method Development for Late Stage Biologics Programs
Favorite
M1130-04-028 - Method Validation of Quantitation IL-17A in Human Serum Using the Ultrasensitive Quanterix Simoa™ Platform
Favorite
M1130-03-019 - Mitigation of Non-Specific Binding of Master Mix Reagents in a CDX-301 Anti-Drug Antibody Assay
Favorite
T0930-04-030 - Modern LC-MS/MS-based proteomics: Powerful tools for reliable discovery of biomarkers and biomedical mechanisms in drug development
Favorite
W1030-04-025 - Multifactorial Troubleshooting and Corrective Action for the Use of Hamilton Automation in Preparation of Plate Acceptance Quality Control Samples in Non-Clinical and Clinical PK Method Development
Favorite
T1430-03-021 - Neurite outgrowth from PC12 cells in presence of nanoparticle covered carbon nanotubes: potential to develop a novel nanoparticle based therapeutic approach?
Favorite
M1530-04-025 - New Immunoassay Platforms: A Practical Guide to Method Validation
Favorite
T1430-03-017 - Non-arrhenius Behavior of Peptide Fibril Formation in the Presence of Stabilizing Excipients and Its Impact on Formulation Development
Favorite
W1230-04-027 - Optimization and Development of an Oligonucleotide Hybridization ELISA for the Quantitative Detection of a Therapeutic Aptamer in Human Plasma
Favorite
M1130-03-021 - Optimization of Sensitivity and Drug Tolerance in a CDX-1140 Anti-Drug Antibody Assay Using Split-Plot Design of Experiment.
Favorite
M0930-03-017 - Optimized Extraction and MFLC-MS/MS Analysis of the Antibody Drug Conjugate SigmaMAb Extracted from Rat Plasma
Favorite
T1130-04-029 - Overcoming Challenges in ADA Assay Development
Favorite
W0930-04-026 - Overcoming Matrix Effect: Development and Validation of an LC-MSMS Assay for the Quantitation of a Clinical-Stage Monoclonal Antibody (mAb) in Human Urine
Favorite
W1230-04-028 - Passive Permeability of the Blood-Brain Barrier to [13C]Sucrose Compared in Young Male and Female Mice
Favorite
M1530-04-026 - Patient-Specific Fluorescence Aberration Profiles During Longitudinal Clinical Trials
Favorite
W1130-04-029 - PD-1-Positive Population in Resting T Cells Identified Using a Qualified Flow Cytometric Method
Favorite
T1030-04-025 - Peptide Mimetics for Pharmacokinetic Analysis of Monoclonal Antibody Therapeutics
Favorite
T1330-04-028 - PHARMACOKINETICS OF NOVEL ORGANIC CARBON MONOXIDE PRODRUG BW-CO-103
Favorite
M1030-03-018 - Photo-curable Hyaluronic Acid Hydrogels for Encapsulation and Tissue Engineering of Human Dental Pulp Stem Cells
Favorite
T1130-03-023 - Potency Assessment of an Antibody Drug Conjugate Using a Dual Approach: Measurement of Specific Binding of Antibody Component and Cytotoxic Efficacy of Drug Conjugate
Favorite
T1130-04-028 - Preclinical Immunogenicity Assessment of Therapeutic Proteins and Antibodies: Applications of a Novel ADA Assay Platform based on Capillary Electrophoresis and Immunodetection
Favorite
T1130-03-017 - Preparation and Characterization of Poly(2-ethyl-2-oxazoline)-Lipid Conjugate as an Alternative to Polyethylene Glycol (PEG) for Surface Modified Long Circulating Liposomes
Favorite
T1130-03-019 - Preparation, Evaluation and In Vitro Characterization of a New 8-aminoquinoline Derivative Loaded Nanostructured Lipid Carriers and Nanoemulsion for Relapsing Malaria
Favorite
T1130-03-021 - Prevention of Cerebral Ischemia/Reperfusion Injury by Neutrophil-Derived Nanovesicles
Favorite
M1530-03-018 - Qualification of a Simultaneous Extraction of Ceftibuten and Clavulanate from Dog Plasma for Analysis by LC-MS/MS to Support Pharmacokinetic Studies
Favorite
W1130-04-027 - Qualification of an IFN-gamma Elispot Assay in the Bioanalytical Laboratory
Favorite
T0930-04-026 - Quantification a Phase II Metabolite in Dog Plasma without Reference Standard Material by LC/MS/MS
Favorite
M1230-03-019 - Quantification of Doxorubicin in Rabbit Liver Tumor Samples after Near Infrared Mediated Photochemotherapy Using HPLC Assay with Fluorescenc Detection
Favorite
W0930-03-021 - Quantification of human IgG in F12 fermentation medium without sample preparation using Flow induced dispersion analysis (FIDA)
Favorite
M1230-04-026 - Quantification of Intracellular Triphosphate Metabolites of Emtricitabine by LC-MS/MS.
Favorite
M1430-03-021 - Quantification of Zolpidem in Human Plasma Using LC-MS/MS
Favorite
T1030-04-030 - Quantitation and Metabolic Profiling of siRNA in Biological Matrices by Liquid Chromatography and High Resolution Accurate Mass (LC/MS-HRAM) Mass Spectrometry
Favorite
M1330-04-026 - Quantitation of 17-β-Estradiol using a very sensitive and high-throughput LC-MS/MS assay: Application to guinea pig pharmacokinetic study
Favorite
W1030-03-019 - Quantitation of Anti-Sense Oligonucleotides in Biological Samples Using a One-Step SPE Method and LC-MS/MS
Favorite
T1430-03-018 - Quantitation of Four Chiral Drug Compounds Simultaneously Using Normal Phase LC-MS/MS Equipped with an APPI Ion Source
Favorite
W0930-03-019 - Quantitation of the Monoclonal Antibody Rituximab Using Volumetric Absorptive Microsampling, Impact-Assisted Extraction, Trypsin Digestion and LC-MRM
Favorite
T1330-03-020 - Quantitative Raman Microanalysis of Drug and Lipid Accumulation in Pulmonary Alveolar Macrophages
Favorite
M1430-04-029 - Rapid LC-MS/MS Assay for CER1, an Essential Omega-O-acylceramide in Primary Human Keratinocytes
Favorite
T1230-03-018 - Redefining Distribution: Immunogenicity Screening Cut Point Determination via Shapiro-Wilk and Skewness
Favorite
W1030-04-026 - Remicade Stabilization with Hydroxypropyl-ß-Cyclodextrins
Favorite
M1530-03-019 - Selective Quantitation of 1,3-Propanediol in Dog Plasma Using Differential Ion Mobility Spectrometry
Favorite
T1330-04-026 - Sensitive LC-MS/MS method for determination of doxorubicin and its metabolite, doxorubicinol, in mouse plasma: Application to determination of new formulation of doxorubicin’s cardiotoxicity in mice
Favorite
M1430-04-028 - Serological Epidemiology of Cytomegalovirus in Pregnant Women Attending at Maternity Lucrécia Paim, Luanda, Angola
Favorite
T1230-04-027 - Seroprevalence of Rubella Virus in Pregnant Women Attending at Maternity Lucrécia Paim, Luanda, Angola
Favorite
T1030-03-022 - Simultaneous Determination of Dexmedetomidine and Its Two N-glucuronides in Adult Critically Ill Patients
Favorite
T0930-04-025 - Simultaneous Determination of Donepezil and Its Three Active Metabolites in Rat Plasma and Brain by LC-MS/MS
Favorite
M1230-04-027 - Simultaneous determination of intracellular concentrations of tenofovir, emtricitabine, and dolutegravir in human brain microvascular endothelial cells using LC/MS-MS
Favorite
T1530-03-018 - Singlicate Analysis: Should This Be the Default for Biomarker Measurements Using Ligand Binding Assays?
Favorite
M1030-04-027 - Slow Off-Rate Modified Aptamer (SOMAmer) as a Novel Reagent in Immunoassay Development for Accurate Soluble Glypican-3 Quantification in Clinical Samples
Favorite
M1130-04-030 - Smart Polymer Reagents for Bioanalytics and In Vitro Diagnostics
Favorite
M0930-04-025 - Specific Identification for Capto Family Chromatography Resins by FTIR and Particle Size Analysis
Favorite
M0930-03-019 - Specific Quantitation of Antisense Oligonucleotides in Plasma Using MSD® Electrochemiluminescence, Hybridization-Based ELISA, and HPLC-MS/MS Platforms
Favorite
T0930-03-019 - Stability of Diluted Neuromuscular Blocking Agents Utilized in Perioperative Hypersensitivity Evaluation
Favorite
T1430-03-022 - Study of Multi-Walled Carbon Nanotubes in Lung Tissue Using a Combined Hyperspectral Imaging Technique
Favorite
M1030-04-025 - Supporting Clinical Trials: The Impact of Sample Preparation on the Quality of Immunology Data
Favorite
M1030-03-020 - Surface Modification of Gemcitabine-Incorporated Acid-Sensitive Micelles Increases Their Cytotoxicity against Macrophages and Tumor Cells
Favorite
T1430-04-029 - Synthesis and Characterization of Tellurium Nanoparticles with Antimicrobial and Anticancer Properties made by Green Synthesis with Orange ,Lemon , and Lime Extract
Favorite
M1030-03-021 - Synthesis and Characterization of Temozolomide Loaded Oleic Acid Magnetic Nanoparticles for Treatment of Glioblastoma Multiforme
Favorite
W0930-03-022 - TANDEM UHPLC OPERATION FOR HIGH-THROUGHPUT LC-MS PEPTIDE MAPPING ANALYSES
Favorite
T1430-03-019 - The Determination of Human PBMC Counts Using a Genomic DNA Standard with Fluorescent Quantitation
Favorite
W1030-04-027 - The Elusive Labile Iron: Bioanalytical Techniques to Measure Iron Speciation in Human Plasma
Favorite
T1230-04-026 - Toxoplasmosis and Pregnancy in Luanda, Angola
Favorite
T1130-03-020 - Ultra Sensitive PK Bioanalysis in Support of the Development of a Bispecific Immune-Recruiting Biotherapeutic
Favorite
T1530-04-028 - Ultra-Sensitive Double Immunocapture-LC/MS Assay for Quantitation of a Therapeutic Protein in Monkey Plasma and Ocular Matrices
Favorite
T1530-04-026 - Understanding of Protein Adsorption to Interfaces Using Sum Frequency Generation Spectroscopy: Effects of Interfacial Interactions on Protein Conformation and Drug Product Stability
Favorite
M1230-03-017 - Use of Alternative Mobile Phase Additives to Improve Reverse Phase HPLC-MS/MS Sensitivity
Favorite
W0930-04-028 - Use Photo-Reactive Excipients to Detect Peptide-Matrix Interactions in Lyophilized Solid
Favorite
W1230-03-020 - Utilizing High-Content Human Protein Microarrays to Identify Potential Biomarkers for Hypertrophic Cardiomyopathy
Favorite
M1530-04-027 - Validation of a Research Use Only Flow Cytometric Assay for Clinical Diagnostic Implementation: HLA-DR Expression on Monocytes
Favorite
M0930-03-020 - Validation of an IC - LC-MS/MS Method for the Quantification of Insulin Aspart in Human Plasma and Serum
Favorite
Clinical Pharmacology
T1230-05-033 - A Comprehensive and Systematic Review of Gastric pH and Factors Affecting Gastric Fluid Volume Dynamics under Fasted and Fed Conditions in Humans
Favorite
M1030-05-036 - A First-Iin-Human Trial Comparing Pharmacokinetics, Pharmacodynamics and Safety of Cannabis Following Multiple, Ascending Doses of Dried Tablets Delivered by Smoking Inhalation
Favorite
M1330-05-034 - A Hybrid PBPK/PD Model for the Effect of Antibody Binding Site Barriers on Antibody Tumor Growth Inhibition in Preclinical Animal Studies
Favorite
M1430-05-039 - A Joint Model Describing Gastric Emptying Driven Pharmacokinetics of Losartan and Its Active Metabolite EXP-3174 Based on Data from Two Bioequivalence Studies
Favorite
M0930-05-034 - A Pharmacokinetic Evaluation of Dabigatran Etexilate, Total Dabigatran, and Unconjugated Dabigatran from Dabigatran Etexilate Mesylate Capsules in Healthy Subjects
Favorite
T1330-05-033 - A Pharmacokinetic Evaluation of Fluticasone Furoate Given Intranasally in Healthy Subjects Using an Ultra-Sensitive Analytical Assay
Favorite
W1230-05-039 - A Physiologically Based Pharmacokinetic Model of Rivaroxaban: Role of OAT3 and P-gp Transporters in Renal Clearance
Favorite
M1430-05-035 - A Preclinical Population Pharmacokinetic Model for INBRX-101, a Recombinant Human AAT-Fc Fusion Protein
Favorite
W1230-05-035 - A Preliminary Quantitative System Pharmacology Model of Chimeric Antigen Receptor T cell Therapy in Cancer Patients
Favorite
T1030-05-040 - A Retrospective Investigation of Post-Complete Response Letter (CRL) Meeting Requests (MRs) Related to Bioequivalence Assessment in Abbreviated New Drug Applications (ANDAs)
Favorite
T1130-05-036 - A Semi-Physiological Modeling and Simulation Approach for Guided Decision Making in R&D
Favorite
M0930-05-035 - Altered Pharmacokinetics in Prolonged Infusions of Sedatives and Analgesics Among Adult Critically Ill Patients: A Systematic Review
Favorite
W0930-05-033 - An Evaluation of the Pharmacokinetics of Abiraterone Acetate and Abiraterone following a Single-Dose Administration of Abiraterone Acetate 250 mg Tablets to Healthy Subjects
Favorite
T0930-05-033 - An Evaluation of the Pharmacokinetics of Tiotropium following a Single-Dose Inhalation in Healthy Subjects Using an Ultrasensitive Bioanalytical Method
Favorite
M1430-05-040 - AR-42 Pharmacokinetics: Estimated versus Measured Patient Body Composition
Favorite
T1530-05-033 - Assessing the Role of Intracellular Binding Protein in Drug-Induced Bile Acid Transporter Inhibition Using Quantiative Systems Pharmacology (QSP) Modeling
Favorite
T1030-05-036 - Assessment of Bioavailability of Diclofenac from Two Topical Drug Products using Pharmacokinetic and Skin (Tape) Stripping Analyses
Favorite
T1030-05-033 - Assessment of Factors Affecting Intrasubject Variability of Drugs Evaluated for Bioequivalence
Favorite
M1030-05-033 - Assessment of Local and Systemic Bioavailability of Lidocaine from Two Lidocaine Topical Delivery Systems using Pharmacokinetic and Skin (Tape) Stripping Analyses
Favorite
T1530-05-034 - Assessment of Pharmacokinetic (PK) Comparability Studies on Prefilled Syringes (PFS) and Autoinjectors(AI) for Biological Products
Favorite
M1230-05-033 - Automated Average Bioequivalence Analysis with Additional Metrics and Statistics to Meet the FDA guidance on Methylphenidate Hydrochloride Using Phoenix® WinNonlin®.
Favorite
M1030-05-038 - Awareness, Attitude, and Knowledge toward Oral Contraceptive Use Among Korean Women
Favorite
T0930-05-035 - Capturing, Counting and Identifying CECs: A Potential Diagnostic Marker for Patients with Pulmonary Arterial Hypertension
Favorite
M0930-05-037 - Characteristics of the Luminal Environment in the Lower Intestine of the Elderly which are Relevant to Drug Absorption and Comparison with the Adult Population
Favorite
M1530-05-035 - Characterization of Plasma Membrane Localization and Phosphorylation Status of Organic Anion Transporting Polypeptide (OATP) 1B1 c.521 T>C Polymorphism
Favorite
T1430-05-035 - Clinical Pharmacokinetic Study of Olmesartan/Amlodipine/Rosuvastatin Fixed-Dose Combination Tablet
Favorite
W1130-05-038 - Common Bioequivalence Deficiencies in Abbreviated New Drug Applications (ANDA) of Transdermal Delivery System (TDS) Products
Favorite
T1430-05-037 - Comparison of the Pharmacokinetics of Four Different Dose-Frequency Combinations of AMZ001 (Diclofenac Gel 3.06%) with Voltaren® (Diclofenac Gel 1%) in Healthy Subjects in a Phase 1 Study
Favorite
W0930-05-034 - Could SNPs Predict Cisplatin Toxicity?
Favorite
M1030-05-034 - Could Toxicities and Oxidative Stress Due to Cisplatin be Ameliorated with the Use of Acetylcysteine without Decreased Antitumor Efficacy? A Randomized Double-Blind Placebo-Controlled Trial
Favorite
M1530-05-039 - Developing a 3-D Cell Culture Model of Chemically Induced Oral Mucositis
Favorite
T0930-05-036 - Development and Evaluation of a New Aspirin Formulation
Favorite
M1230-05-035 - Development and Validation of a PBPK Model to Predict Plasma and Sputum Exposures after IV, Oral or Inhalation Administration of Ciprofloxacin in Healthy Volunteers and Cystic Fibrosis Patients
Favorite
M1230-05-037 - Development and Verification of Population Level IVIVC Using Mechanistic PBPK Modeling for Trazodone Extended Release Formulations to Support Biowaiver for SUPAC Changes to the Formulation
Favorite
W1030-05-034 - Development of a Microfluidic Cell Culture Platform for High Throughput Quantitative Drug Screening
Favorite
M1430-05-033 - Development of a Population Pharmacokinetic Model to Characterize Cocaine and Metabolites Behavior in Mice
Favorite
W1230-05-038 - Development of an Ocular Physiologically-Based Pharmacokinetic Model to Describe the Impact of Formulation Attributes on the Disposition of an Antibiotic Applied on the Rabbit Eye
Favorite
T1130-05-035 - Development of In Vitro In Vivo Correlation Model for Testosterone Transdermal Gel Product
Favorite
W1030-05-037 - Development of the Lipid Nanoparticles Loaded with Immunostimulatory Oligodeoxynucleotide for Cancer Therapy
Favorite
W1130-05-034 - Disease Progression Modeling of Placebo-response in Analgesic Clinical Trials
Favorite
M1530-05-037 - Do Uremic Solutes Potentially Affect UDP-Glucuronosyltransferase (UGT) Enzymes?
Favorite
M1130-05-037 - Droplet Evaporation from a Solution-Based Metered Dose Inhaler: A Computational Approach
Favorite
W1230-05-033 - Drug-Induced TMDD: A Novel Class of PK Models for Immune-Stimulating Therapies
Favorite
M1530-05-034 - Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Kinetics and Inhibition of Bile Acid Transport by Cholestatic Medications
Favorite
T1430-05-036 - Effect of Adhesion on Pharmacokinetics (PK) of Transdermal (TDS) Topical Products
Favorite
M1130-05-036 - Effect of Counseling on Cost Effectiveness Analysis in Diabetes Mellitus Patients
Favorite
W0930-05-036 - Effect of CYP2D6 Genetic Polymorphism on the Pharmacokinetics of Zolpidem
Favorite
M0930-05-033 - Evaluation of Dermal Open Flow Microperfusion (dOFM) as a General Methodology to Assess the Bioequivalence of Hydrophobic, Protein-Bound Topical Drug Products
Favorite
W1130-05-036 - Evaluation of Pain from Microneedle Use in the Oral Cavity of Human Volunteers
Favorite
W1030-05-033 - Evaluation of Reapplication and Controlled Heat Exposure on Oxybenzone Permeation from Commercial Sunscreen Using Excised Human Abdominal Skin
Favorite
T1330-05-035 - Exosomes as Delivery Vehicles for Biomolecules
Favorite
W1230-05-036 - Extended Physiologically-Based Pharmacokinetics (PBPK) Modeling Approach for Effects of Obesity
Favorite
T1130-05-034 - Extracellular Matrix Softening Promotes SH-SY5Y Neuroblastoma Softening and Actin Depolymerization to Selectively Increase Abeta(1-42) Endocytosis
Favorite
T1530-05-038 - Formation of Primaquine-5,6-orthoquinone, the Putative Active and Toxic Metabolite of Primaquine via Direct Oxidation in Human Erythrocytes
Favorite
T1130-05-033 - GAA-iTEM, an In Silico Personalized Prediction Tool to Identify Infantile Pompe Disease (IPD) Patients at High Risk of Developing Anti-drug Antibodies (ADA)
Favorite
M1430-05-037 - Gastrointestinal Transit Kinetics of Cefaclor and Cefadroxil in Cystic Fibrosis (CF) Patients and Healthy Volunteers Compared via Population Pharmacokinetics
Favorite
M1330-05-037 - General Pharmacokinetic Features of Small Molecule Compounds Exhibiting Target-Mediated Drug Disposition (TMDD)–A Simulation-Based Study
Favorite
T0930-05-037 - Generic Transdermal Drug Delivery System (TDDS): Region-Specific Requirements
Favorite
T1030-05-039 - Histological Evaluation of Obstructed Insulin Pump Catheters Explanted from Patients
Favorite
M1330-05-036 - HTPK: Conducting PK Modeling and Simulations at High Speed
Favorite
T1130-05-038 - Importance of Physiologically Based Pharmacokinetic (PBPK) Modeling Approaches for Development of Dissolution Method; To Learn from Clinical Non-bioequivalent (BE) Data
Favorite
M1530-05-038 - In Vitro Evaluation of Metabolism-Based Drug Interactions with Sunscreen Ingredients
Favorite
W1230-05-037 - In Vitro to In Vivo Extrapolation (IVIVE) of Itraconazole Precipitation using a Biphasic Dissolution Test and Mechanistic Absorption Model
Favorite
M1130-05-033 - In Vivo Pharmacokinetics of Levofloxacin Niosomes
Favorite
M1330-05-033 - Inferring Target Occupancy from Fitting Nonlinear-PK Data with Mechanistic PKRO Model for Pembrolizumab
Favorite
W1030-05-039 - LC-MS/MS Method Validation of Loperamide Hydrochloride for an In Vitro Transporter Assay
Favorite
T1530-05-036 - Liver Safety Comparison of Two Treatments for Autosomal-Dominant Polycystic Kidney Disease (ADPKD) Using Quantitative Systems Toxicology Software (DILIsym)
Favorite
T1230-05-036 - Mechanistic Prediction of Effect of P-glycoprotein Inhibition on Oral Absorption and Disposition of Vemurafenib into the Brain Using IVIVE-PBPK
Favorite
M1330-05-035 - Modeling of the Antihypertensive Effect of Irbesartan and Hydrochlorothiazide Combination
Favorite
M1230-05-036 - Multi-Phase Multi-Layer Mechanistic Physiologically Based Pharmacokinetic Dermal Absorption Model Verification including Inter and Intra Individual Variability Assessment Using Nicotine as Model Drug
Favorite
W1030-05-035 - Neuroprotection by Activation of a TrpV1 Receptor Using Resiniferatoxin, against 6-OHDA Induced Toxicity and Revealing TrpV1 Mediated Pathway for Neurotrophic Activity in Neurodegenerative Disorders
Favorite
T1530-05-039 - P-Glycoprotein Drug Interaction Risk Assessment Based on In Vitro Data; Comparison of a Vesicle- Versus a Cell-Based Assay
Favorite
M1130-05-035 - Pharmacokinetic Modeling of the Effect of Recombinant Human Hyaluronidase (rHuPH20) in Subcutaneous Absorption
Favorite
W0930-05-035 - Pharmacokinetics Interaction between Metformin Hydrochloride 1500 mg and Rosuvastatin 20 mg in Healthy Subjects
Favorite
T1330-05-036 - Pharmacokinetics, Safety and Efficacy of Solid Lipid Boswellia serrata Particles (SLBSP) For Symptomatic Treatment of Osteoarthritis of Knee.
Favorite
T1030-05-035 - Pharmacokinetics/Pharmacodynamic Studies of Metformin in a Phase I Dose-Escalation Study in Locally Advanced Head and Neck Squamous Cell Carcinoma Patients
Favorite
M1530-05-033 - Photochemical Internalization to Improve the Therapeutic Indices of Chemotherapy Drugs
Favorite
T1230-05-038 - Physiologically Based Pharmacokinetic Modeling of Carvedilol in CYP2D6 Genetic Polymorphism
Favorite
T1130-05-039 - Physiologically Based Pharmacokinetic Modeling of Tamsulosin in relation to CYP2D6 genetic polymorphism
Favorite
T1030-05-034 - Plasmatic and Urinary Biomarkers of Oxidative Stress and Toxicities Induced by Cisplatin in Head and Neck Cancer Patients
Favorite
W1230-05-034 - Population Pharmacokinetic-Pharmacogenetic study of atazanavir/ritonavir in Thai HIV-infected patients
Favorite
M1430-05-034 - Population Pharmacokinetics of Durvalumab Following Combination Therapy with Olaparib in SCLC, Ovarian, Breast and Gastric Cancer Patients
Favorite
M1430-05-036 - Population Pharmacokinetics of Rituximab in Membranous Nephropathy
Favorite
M1430-05-038 - Population Pharmacokinetics of Subcutaneously- and Intradermally- Administered Glucagon in Type 1 Diabetic Patients
Favorite
W1130-05-037 - Preclinical activity and pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD+ AML
Favorite
T1030-05-038 - Pre-Clinical and Clinical Assessment of Letrozole Steady-State Pharmacokinetics in Malignant Gliomas: Application of Physiologically-Based PK Modeling to gain Quantitative and Mechanistic Insights
Favorite
T1230-05-037 - Predicting Depth Resolved Concentrations in the Dermis using PBPK modelling: Design, development and verification of the model with five drugs
Favorite
W1030-05-038 - Proteasome Inhibitors Bortezomib and Carfilzomib Stimulate the Transport Activity of Human Organic Anion Transporter 3
Favorite
M1130-05-034 - Reference-Scaled Average Bio-Equivalence (SABE): A Promising Statistical Approach to Analyze Cutaneous Pharmacokinetic Results for Topically Applied Drug Products
Favorite
W1030-05-036 - Regulation of Human Organic Anion Transporters 3 by Protein Kinases A: Crosstalk between Sumoylation and Ubiqitination
Favorite
T1030-05-037 - Relative Bioavailability, Effect of Food, Gender Difference, Safety, and Tolerability of Etrasimod, a Next-Generation, Oral, Selective Sphingosine 1-Phosphate Receptor Modulator, in Healthy Subjects
Favorite
T1330-05-037 - Review of Substrates and Inhibitors Used in Transporter-Mediated Clinical Drug-Drug Interaction Studies
Favorite
M0930-05-036 - Safety, Pharmacokinetics and Pharmacodynamics of CNTO 7160, an Anti-IL-33R Monoclonal Antibody, in a First-in-Human Study in Healthy Subjects, Subjects with Asthma, and Subjects with Atopic Dermatitis
Favorite
T1230-05-034 - Tackling Ineffective Metformin Dosing in Type 2 Diabetic Children Using a Physiologically-Based Pharmacokinetic Model and Individualized Dosing
Favorite
T0930-05-034 - The effects of Warfarin long use in quality of life and treatment adherence in patients with Primary Antiphospholipid Syndrome.
Favorite
T1430-05-033 - The efficacy and safety effects of Cordyceps militaris extract supplement (D.C. Daily®) in vivo models and clinical trial
Favorite
M1530-05-036 - Transplacental Transfer of Doxorubicin and Doxil® (PEGylated Liposomal Doxorubicin) across BeWo b30 Trophoblast Cell Monolayers
Favorite
T1130-05-037 - Understanding the Impact of Age-Related Changes in Paediatric Gastrointestinal Solubility by Multivariate Data Analysis
Favorite
M1230-05-038 - Updated Physiologically Based Pharmacokinetic (PBPK) Model for Acetaminophen Metabolism with an Emphasis on Phase I Metabolism
Favorite
M1230-05-034 - Use of Electronic Medical Records and a DNA Biobank to Develop a Population Pharmacokinetic Model for Tacrolimus
Favorite
T1530-05-035 - Using Visualization to Address the Reliability of Sources of Initial Parameter Values in a Quantitative Systems Pharmacology Model
Favorite
Formulation and Quality
T1230-12-092 - 4D Printing for Fabrication of Retentive Intravesical Drug Delivery Systems Based on Poly(vinyl alcohol)
Favorite
T1330-11-088 - A 14 Day Gastric Resident Oral Formulation of Ivermectin for Prevention of Malaria Transmission
Favorite
M1230-09-069 - A 3D Bioprinted In Situ Conjugated-co-Fabricated Scaffold for Bone Tissue Engineering Applications
Favorite
T1030-09-065 - A Comparative Study of Two Liposomal Delivery Systems Targeted for Glioblastoma Multiforme
Favorite
W0930-12-095 - A Comparison of Formulation Approaches for a Small Molecule with a Short Biological Half-Life for the Treatment of Irritable Bowel Syndrome (IRB)
Favorite
T1330-08-063 - A Dual Delivery System for Antibiotics and Probiotics: An In Vitro, Ex Vivo, In Vivo and In Silico Evaluation
Favorite
M1030-07-049 - A Flow-Through Dissolution Method for Evaluation of Drug Release from Manipulated Abuse Deterrent Formulations
Favorite
T1230-12-091 - A Formulation-by-Design Approach to Design and Fabricate FDM 3D-Printed Tablets with Pre-defined Release Kinetics
Favorite
M1330-07-055 - A General Practical Approach for Trace Level Determination of Arylamine Genotoxic Impurities in Drug Substances
Favorite
M1130-09-070 - A Low Volume Microfluidic Multiplexed Viscometer for Newtonian and Non-Newtonian Fluids
Favorite
M1430-13-099 - A Material-Sparing Approach for Developing Sildenafil Orally Disintegrating Tablet
Favorite
T1030-10-073 - A Mathematical Model Linking the Formation of Amorphous Solid Dispersions with Hot-Melt-Extrusion Process Parameters
Favorite
M1230-07-050 - A Mathematical Model to Determine Actual Drug Release Kinetics from Nanocarriers using Dialysis Methods
Favorite
T0930-12-093 - A Microfluidic Platform for Rapid Production of Scalable, Tunable, and Controlled Lipid Nanoparticles
Favorite
M1230-09-072 - A Modified USP Induction Port To Characterize Nasal Spray Plume Geometry And Predict Turbinate Deposition Under Flow
Favorite
T1430-10-080 - A New Excipient for Effective Taste Masking at Low Coating Levels
Favorite
W1130-13-103 - A Novel Approach for the Fabrication of Nanoparticle Agglomerates for Pulmonary Drug Delivery
Favorite
T1530-07-050 - A Novel Approach to Keloid and Hypertrophic Scar Therapy: Sustained Release of Proteases from PLGA Microspheres.
Favorite
M1030-10-074 - A Novel Architecture to Enable High Active Loading of Tablets of Amorphous Spray Dried Dispersions
Favorite
W1130-08-063 - A Novel Cyclodextrin-Based Pickering Emulsions for Prolonging the Duration of Topical Local Anesthesia
Favorite
T0930-10-079 - A Novel Solid Self-nanoemulsifying Drug Delivery System (S-SNEDDS) for Improved Stability and Oral Bioavailability of an Oily Drug, 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol
Favorite
T1430-07-049 - A Novel S-sulfhydrated Human Serum Albumin Preparation Suppresses Melanin Synthesis
Favorite
W1130-11-085 - A Patient-Centric Approach: Formulation of Prolonged Release Microparticles to be Used in Oral Suspensions for Older Patients with Dysphagia
Favorite
T1130-13-104 - A PBPK Model of the Negative Effect of Chitosan on Acyclovir Absorption: The Mucus-Chitosan Interaction
Favorite
M1430-11-083 - A Platform Formulation Approach for Rapid Development of Controlled Release Multiparticulates for Early Clinical Studies
Favorite
T1130-08-062 - A Promising Lyophilized Orodispersible Tablets of Ethyl Morphine Hydrochloride for Clinical Use
Favorite
M1330-07-056 - A Quality by Design Approach to Analytical HPLC Method Optimization
Favorite
T1330-12-090 - A Review of Recent Progress in GDUFA Research Program on PLGA-Based Drug Products: Three Case Studies
Favorite
M1030-10-079 - A Simple Rheological Method for Polymer Selection in Amorphous Drug Solid Dispersions
Favorite
T1130-07-051 - A Simple, Accurate and Economical Method for Quantitative Estimation of Calcium Acetate Capsules by High Performance Liquid Chromatography Using UV Detector
Favorite
W0930-09-067 - A Smart Macrophage Bioreactor for Deep Penetrating Delivery of Anti-Tumor Peptide for Breast Cancer Therapy
Favorite
T1030-11-086 - A Spectroscopic Assessment of Interaction Anisotropy in Pharmaceutical Materials: Assessing Potential Drug Candidates for Direct Compression
Favorite
M1330-11-081 - A Study of the Impact of Excipient Shielding on Initial Drug Release Using UV Imaging
Favorite
M0930-09-071 - A Systematic Approach to Formulate and Evaluate the Stability of Topical Creams with High Concentrations of Transcutol® HP
Favorite
M0930-09-070 - A Transdermal Electro-Modulated Hydrogel- Microneedle Device for Chronic Pain
Favorite
T1230-07-050 - A Validated 19F NMR Technique to Assay Quantitatively Fluorinated Synthetic Cannabinoid Agonists
Favorite
T1030-13-099 - Absorptive Dissolution Testing of Supersaturating Systems: Impact of Absorptive Sink Conditions on Solution Phase Behavior and Mass Transport
Favorite
M1230-09-070 - Abuse Deterrent Immediate Release Egg-Shaped Tablet Using 3D Printing Technology: Multifactorial Design to Optimize Release and Extraction
Favorite
M1530-11-081 - Abuse-Deterrent/Crush-Resistant (ADCR) System: A Novel In Situ Sintering Matrix
Favorite
T1430-10-075 - Acoustic Detection of Capping Risk in Solid Dosage Forms
Favorite
W0930-08-060 - Activity and Delivery of Novel mitoNEET Ligand NL-1 for Cerebral Ischemia Reperfusion Injury
Favorite
W0930-10-077 - Adsorbing the Poorly Water Soluble Drug on Porous Calcium Silicate by Sealed Heating Method
Favorite
T1530-10-077 - Advantage of Various Pellet Coating Techniques Using Hypromellose Acetate Succinate (HPMCAS)
Favorite
W1230-11-082 - Advantages of Spongy PLGA Microsphere as Parenteral Depot Injection
Favorite
T1230-10-073 - Altering Particle Size and Shape during the Precipitation of API in Aqueous Solvent Systems
Favorite
M1430-10-080 - Amorphous-Based and Crystalline-Based Solid Dispersion-An Industrial Assessment
Favorite
M0930-13-103 - An In Vitro Biorelevant Assessment of Prussian Blue
Favorite
M1130-13-101 - An Integrated Experimental and Modelling Approach to Characterize the Precipitation Kinetics of Compounds with Poor Aqueous Solubility: From In Vitro to In Vivo Predictions
Favorite
T1530-09-068 - An Investigation into the Thermal Stability of a Cocrystal Form of Hydrochlorothiazide/Nicotinamide: Thermally Induced Coamorphous Drug Forms
Favorite
T1530-07-049 - An Isolated Perfused Rat Lung Model for Studying Controlled and Targeted Release of Fasudil, an Anti-PAH Drug from Peptide Grafted Liposomal Formulations
Favorite
T1230-09-067 - Analgesic Effect of Diclofenac Sodium Loaded Dissolving Microneedle Patches in Treatment of Glacial Acetic Acid Induced Acute Inflammation in Rats
Favorite
T1530-08-062 - Antibacterial Agent Loaded Nano-lipid Carriers for the Selective Mitigation of Pathogenic Bacteria and Their Biofilms in the Skin
Favorite
M1130-08-057 - Anticancer Effects of Tannic Acid on Non-small Cell Lung Cancer
Favorite
T1030-08-060 - Antinociceptive Effects of a Multifunctional Burn Wound Dressing in Rat Model of Second Degree Burn Injury
Favorite
M1430-10-073 - API and Precipitation Inhibitor Co-Loaded Mesoporous Silica: A Novel Synergistic Formulation Type with Advantageous Dissolution Performance
Favorite
T0930-11-081 - Apparent Molal Volumes of a Non-ionic Surfactant Derived from Castor Oil in Microemulsions with Various Polar Oils
Favorite
T1230-07-053 - Application of 19F Solid-State NMR Spectroscopy for Detection of Low Levels of Crystalline Content in Amorphous Solid Dosage Forms
Favorite
M1430-07-055 - Application of 2D NMR for Structural Characterization of Monoclonal Antibodies
Favorite
W1030-09-070 - Application of 3D Printing Technology and Quality by Design Approach for the Development of Age Appropriate Formulation
Favorite
T1330-11-081 - Application of Cellulosic Polymers in Delayed Release Coating of Diclofenac Sodium Tablets
Favorite
W0930-07-055 - Application of DOSY NMR to Droplet Size Measurement for Emulsion Drug Products
Favorite
M1530-07-055 - Application of NIR to Monitor the Secondary Drying of a Spray Dried Intermediate
Favorite
W1030-13-103 - Application of QbD Principles to Late Phase Clinical Development
Favorite
W1230-11-084 - Application of Thermo-Sensitive Hydrogel for Changing the PK of PPS1D1-M to Avoid Acute Toxicity
Favorite
M1130-13-102 - Applying Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation for Quality Risk Assessment: The Impact of Drug Substance Particle Size of BCS Class II Drug on the In Vivo Performance
Favorite
T1530-10-079 - Are Excipients Inert? Phenytoin: A Follow-up Half a Century Later with New Incompatibility Insights
Favorite
T1230-07-051 - Artificial Gut Simulator for Simultaneous Evaluation of Dissolution and Absorption of Supersaturating Drug Formulations
Favorite
T1130-11-088 - Asparagine Deamidation in the Fc Region of Therapeutic Monoclonal Antibody–Effect of Selected Mutations on Fc-Receptor Binding and Deamidation
Favorite
T1530-08-064 - Assessment of Bioavailability of Rivastigmine from Two Rivastigmine Transdermal Delivery Systems with and without Exposure to Heat Using In Vitro Permeation Test (IVPT)
Favorite
M1130-12-089 - Assessment of Compressibility and Compactibility of Pharmaceutical Powders and Their Binary Mixtures Using Percolation Theory
Favorite
M1230-11-081 - Assessment of Drug Gastrointestinal Supersaturation Using In Vitro Dissolution Absorption System 2 (IDAS2)
Favorite
T1130-07-054 - Assessment of Drug Quality Using the Regulatory Framework of the FDA-DOD Shelf-Life Extension Program to Extend the Expiration of Medical Drug Products
Favorite
M1430-12-092 - Assessment of Quality Control Parameters and In Vitro Bioequivalence/Interchangeability of Multisourced Marketed Metformin Hydrochloride Tablets in the State of Qatar
Favorite
M1530-08-063 - Assessment of Radiation Sterilization Impact on Rheological Properties and In Vitro Release Profiles of a Thermo Responsive Topical Gel
Favorite
T0930-11-084 - Assessment of the pH-Stability Profile of Epinephrine for Sublingual Administration
Favorite
W0930-10-073 - Autoclave Vial Delamination Revisited: SWFI vs. Captisol® Solutions
Favorite
W0930-07-052 - Automated Particle Count Analysis for Protein Formulation Optimization to Minimize Aggregation and Perform USP 787 Subvisible Particulate Matter Testing
Favorite
W0930-12-093 - Batch Age Effect on Potency and Pharmaceutical Quality of Brand Levothyroxine Sodium Tablets
Favorite
W0930-12-091 - Berberine Nanoparticles with Anti-Alzheimer Potential: Effect of Coating on Cerebrovascular Amyloid Targeting and Nanotoxicity in Rats
Favorite
M1030-09-068 - BergaCare SmartLipids® - Development of Commercial Concentrates of Phenylethyl Resorcinol for Skin Whitening
Favorite
W1130-07-050 - Bile Based Vesicles for Hepatocytes Specific Oral Delivery of Direct Acting Antiviral (DAA): Assessment of the Targeting Ability of the Charged and β-sitosterol Decorated Vesicles
Favorite
M1330-08-059 - Bioadhesive Nanocarrier Improve Cytotoxicity of Piplartine and Mammary Tissue Targeting by Intraductal Administration: A New Strategy for Treatment of In Situ Ductal Carconoma
Favorite
M1230-12-092 - Biodegradable Polymeric Micelles for Delivery of Irinotecan
Favorite
M1030-08-061 - Biodistribution Study of Intranasally Delivered liposomes
Favorite
T1330-08-060 - Bioengineering of Thermoreversible Hydrogels Loaded with Bone Morphogenic Protein-2
Favorite
M1430-09-067 - Biomimetic Formulation of Clofazimine Hydrochloride Microcrystals for Local Administration
Favorite
M0930-12-092 - Biomimetic Nanostructured Lipid Carrier Containing Paclitaxel Coated with Platelet Membrane
Favorite
T1430-07-051 - Bioreducible Cross-Linked Polypeptide Micelles for Enhanced Cancer Combination Therapy
Favorite
T1530-13-100 - BiPhasic Dissolution Tests Conducted at Low Buffer Capacity Conditions
Favorite
T1230-11-084 - Box-Behnken Design for the Optimization of Sustained-Release Tablet Formulation for Bupropion Hydrochloride
Favorite
T0930-08-064 - Brain Targeting of Ginsenosides Self-nanoemulsifying Drug Delivery System to Ameliorate Metabolic Syndromes and Keep Homeostatic Balance
Favorite
T1530-07-054 - Breast Cancer Chemoprevention: A New Liquid-Crystalline System for Sustained Local Drug Release
Favorite
M1130-10-073 - Built-In Quality of Cocrystal between Indomethacin and Saccharin at High Shear Granulation Process
Favorite
M0930-07-055 - Can One-Stage In Vitro Dissolution Using Water as Medium Represent Guaifenesin Release from Extended-Release Bilayer Tablets?
Favorite
M1330-10-075 - Can the Commonly used pH-Stat Titration Method be Improved Upon for Correlating Drug Release with Lipid-Based Formulation Digestion?
Favorite
T1130-07-049 - Category 1 Assessment: Vaping of Abuse Deterrent Opioid Formulations
Favorite
T1130-08-061 - Cell-Penetrating Peptide Enhances Efficacy of Paclitaxel Nanomicelles in Traditional 2D Monolayer Culture and Multicellular Tumor 3D Spheroids of Triple Negative Breast Cancer Cells
Favorite
M1130-09-072 - Challenges Encountered in Evaluating the Compatibility of Broadly Neutralizing Antibodies with Intravenous (IV) Fluids
Favorite
T1030-07-052 - Characterization and Quantification of Five Synthetic Cannabinoid Agonists (SCA) Using NMR and UHPLC-QTOF/MS/MS
Favorite
T1130-10-074 - Characterization of API Bulk Properties to Identify Quality Attributes to Support Formulation of Drug Product
Favorite
M1330-08-060 - Characterization of Drug-Loaded Milled Extrudate Particles Produced by Hot Melt Extrusion Technology for Dry Powder Inhalers
Favorite
W0930-08-061 - Characterization of GLUT-1 Targeted Nanoparticles for Drug Delivery to Brain for Treatment of Alzheimer’s Disease
Favorite
M1130-11-081 - Characterization of Lyophilized Cake Appearance and Compressive Strength
Favorite
W1230-10-076 - Characterization of SeaGel® Films for Soft-shell Capsule Applications
Favorite
M0930-09-065 - Characterization, Formulation and Topical Delivery of Terbinafine
Favorite
M1530-09-067 - Characterizing the Nature and Strength of Drug-Polymer Complexes in Aqueous Solution Using Analytical Ultracentrifugation
Favorite
T1230-13-097 - Clay-Polymer Nanocomposites Prepared by Reactive Melt Extrusion for Sustained Drug Release
Favorite
M0930-08-059 - Coated PLGA-Bevacizumab Implants for Long-Acting Anti-VEGF Efficacy in a Rabbit Retinal Vascular Leakage Model
Favorite
M1530-09-065 - Cocrystal Dissolution into Constant pH Media: Model Analysis
Favorite
T1430-09-072 - Cocrystal Superior Dissolution Performance and the Role of Supersaturation Index in Biorelevant Media
Favorite
W0930-11-083 - Co-extruded Fixed Dose Combination Products with Enabled Properties for the Treatment of Cardiovascular Diseases
Favorite
T0930-13-098 - Cold Flow Properties of Tulobuterol Patches
Favorite
T1230-11-083 - Colon Targeted Multiple Unit Pulsatile Drug Delivery of Ketoprofen - Eudragit® FS100 Pellets Prepared via Hot Melt Extrusion Technology
Favorite
T1130-11-084 - Colon-Targeted Lipase Releasing Microparticles for the Prevention of Diarrhea and Steatorrhea
Favorite
T0930-13-100 - Common Deficiencies in the Validation of Regulatory Analytical Procedures for ANDA Supplemental Applications
Favorite
T0930-11-087 - Compaction Performance and Mechanical Properties of Caffeine Cocrystals: A Polymorphic Study
Favorite
M0930-13-100 - Comparative Assessment of the Physical and Structural Similarity of Topical Drug Products containing Lidocaine and Prilocaine
Favorite
M1430-12-094 - Comparative Characteristics of Ovarian Cancer-Derived Bionanocarriers and Traditional Exosomes
Favorite
W0930-13-102 - Comparative Efficiency of GC/MS and LC/MS for Determination of Non-volatile Acidic Leachables
Favorite
W0930-09-066 - Comparative Permeation Study of a Novel Buprenorphine Transmucosal Dosage Form versus Sublingual Tablet and Buccal Film
Favorite
M1530-07-054 - Comparative Physicochemical Characterization between Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection
Favorite
W1130-09-072 - Comparative Stability of Oral Vitamin K Solutions Stored in Refrigerated Amber Plastic Syringes
Favorite
T1230-09-066 - Comparative Studies on Amphotericin B Nanosuspensions Prepared by High Pressure Homogenization Method and Anti-Solvent Precipitation Method
Favorite
T1230-08-058 - Comparison of Bilayer Hydroxyethylmethacrylate-Hyaluronate and Composite HPMC-Hyaluronate Films as Potential Ocular Drug Delivery Systems for Potential Treatment of Glaucoma
Favorite
T1030-13-102 - Comparison of Cataflam® Performance in the Dynamic Gastric Model (DGM) with a Human Aspiration Study
Favorite
M1030-07-055 - Comparison of Dissolution Behaviour of Aerosols from Pressurized Metered Dose Inhalers When Delivered by Next Generation Impactor and PreciseInhale®
Favorite
T1230-12-094 - Comparison of Hildebrand and Hansen Solubility Approaches in the Construction of Drug-Excipient Thermodynamic Phase Diagrams Using Flory-Huggins Solution Theory
Favorite
W1230-13-097 - Comparison of Posttranslational Modification and the Functional Impairment of Human Serum Albumin in Commercial Preparations
Favorite
T1030-13-104 - Comparison of Solubility and Dissolution Behavior of Ibuprofen or Ketoconazole in Fed State Simulated Intestinal Fluid (FeSSIF, Made from Commercial Powder or from Scratch) or USP Buffer
Favorite
W1130-10-076 - Comparison of the Results Generated and Methods Employed by Shear Cells of Varying Sizes and Geometries with Common Excipients and Active Pharmaceutical Ingredients
Favorite
M1330-09-071 - Comparison of the Surface Energetics of Various Co-crystal Systems with Their Physicochemical Properties
Favorite
W1130-10-075 - Complexity of Setting Compendial Specifications for Excipient Composition and Impurities
Favorite
T0930-07-050 - Comprehensive Analysis of Polysorbate 80 Degradation Using Mass Spectrometry and Automated Polysorbate Species Identification
Favorite
M1230-09-065 - Computer-Aided Geometric Design of Outlet Channel in the Mouthpiece of DPI Device
Favorite
M1030-11-086 - Conformational Structure and Physical Stability of Teriparatide: Implication on Product Quality
Favorite
T1430-09-065 - Congruent Release of Drug and Polymer: A Sweet Spot in the Dissolution of Amorphous Solid Dispersions
Favorite
T1130-07-052 - Construction of Drug-Lipid Thermodynamic Phase Diagrams by Analysis of Melting Point Depression through Application of Flory-Huggins Interaction Theory
Favorite
T1430-12-093 - Continuous Preparation of Self-assembled Clofazimine-Loaded Particles by Flash Nano-Precipitation (FNP)
Favorite
W1230-12-091 - Contribution of Crystal Lattice Energy on the Dissolution Behavior of Eutectic Solid Dispersion
Favorite
M1330-13-102 - Contribution of Surface Modification in Cellular Uptake, Endosomal Escape and Transfection Efficiency of Dual-Functionalized Liposomes Loading Plasmid DNA
Favorite
W1030-07-054 - Controlled Release Mini-tablets: An Innovative Approach to Improving Pediatric and Geriatric Patient Compliance
Favorite
W1030-07-056 - Controlled Release of Doxorubicin Using Fe-Based Nano Biocomposite Impregnated in Bio Polymeric Matrix
Favorite
M1230-09-071 - Correlation between Drug-Lipid Interaction and Phase Solubility for Preformulation of Hydrophilic Drug Loaded Solid Lipid Nanoparticles
Favorite
W1230-12-090 - Correlation between Skin Irritation Potentials of Cosmetic Raw Materials Evaluated by Different Skin Irritation Testing Methods Using Reconstructed Human Skin Tissues and Human Skin Cells
Favorite
M1230-08-061 - Corticosteroid-Loaded Biodegradable Nanoparticles for Treating Experimental Autoimmune Uveitis
Favorite
M0930-09-072 - Co-Spray Dried Inhalable Netilmicin/L-leucine Dry Powder with Hygroscopicity Reduction to Improve Aerosolization Performance for Respiratory Infections Treatment
Favorite
M1430-11-082 - Critical Steps Design and Optimization in Modified Release Pellets by Extrusion–Spheronization Technique
Favorite
T1430-09-067 - Crystal Engineering of Novel Pharmaceutical Cocrystal of Itraconazole with Suberic Acid
Favorite
M1230-10-076 - Crystallinity Risk Assessment in the Performance of Amorphous Solid Dispersions
Favorite
W1230-12-092 - CytoVessel – A Novel Hermetic Dissolution System for Hazardous Drugs
Favorite
T1130-12-093 - Decreasing Pharmaceutical Powder Cohesiveness with Mesoporous Silica Particles
Favorite
M1530-10-077 - Degradation Kinetics Study of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) by a Validated Stability-Indicating RP-HPLC Method
Favorite
T1030-09-066 - Delayed Release Coating Formulations Targeting Lower GI Tract
Favorite
W1130-08-061 - Demonstration of Sweat Resistant Transdermal Drug Delivery System
Favorite
M0930-09-067 - Dermal Patch for Extended Delivery of Pirfenidone to Deep Partial-Thickness Burns
Favorite
M1230-09-067 - Design and Characterization of Shear-Sensitive Fattigation-Platform Albumin Nanoparticles
Favorite
W1130-07-054 - Design and Evaluation of Esomeprazole Enteric Coated Micropellet Formulations
Favorite
M1530-08-057 - Design and Evaluation of Poly lactic-co-glycolic Acid Based In Situ Film Forming System for Topical Delivery of Trolamine Salicylate
Favorite
T1530-13-097 - Design of a New Disintegration Test System for Evaluation of Orally Disintegrating Films
Favorite
W1030-08-064 - Design of Ionic Liquid-Based Film-Forming Oral Spray Formulations of Vitamin B12
Favorite
W1030-09-069 - Design of Patient-Centered Sublingual Dosage Form Containing Low Dose Emergency Medicine with Content Uniformity and Taste Masking
Favorite
M1230-13-103 - Design, Development and Characterization of Cannabidiol Loaded Microspheres for Ovarian Cancer Therapy: In Vitro and In Ovo Evaluation
Favorite
W1030-07-052 - Design, Development, and Characterization of Imiquimod-Loaded Chitosan Films
Favorite
W1230-08-058 - Design, Optimization and Preparation of Nanotechnological Approaches for Topical and Transdermal Pathways
Favorite
M1330-13-098 - Designing Biocompatible Polymer for Efficient Oral Gene Delivery
Favorite
W1230-12-093 - Detection of the Onset of Aggregation as a Function of pH of Iron Oxide Nanopowder by Dynamic Light Scattering
Favorite
T1030-10-077 - Determination of Drug Release Rates during an In Vitro Self-Emulsification Process Using Dynamic Pulsatile Microdialysis (Dynamic PMD)
Favorite
M1230-07-053 - Determination of Sodium Chloride in Yeast Extract by Ion Chromatography
Favorite
T1030-10-075 - Determination of the Effects of the Surfactant Sodium Lauryl Sulfate (SLS) on the Free Dissolved Concentrations of Ibuprofen, Benzocaine and Griseofulvin in Solution Using Pulsatile Microdialysis (PMD)
Favorite
W1030-11-087 - Determination of the Upper Limit of the Metastable Zone for Supersaturated Diazepam
Favorite
T1230-13-098 - Determining the Formulation, Processing and Release of a Sustained Release Softgel Capsule
Favorite
T1330-13-098 - Developing Cold Chain Independent Vaccines - Spray-drying of Virosomes to Produce Dry Powder Formulations
Favorite
T1030-11-085 - Developing Sustained Release Delivery Systems for Hydrogen Sulfide: Influence of Dissolved Oxygen in Releasing Media and its temperature
Favorite
W1230-13-101 - Development and Approval of a Palatable Glycopyrronium Bromide Liquid Formulation for Pediatrics
Favorite
T1530-08-057 - Development and Characterization of a Transdermal Patch for 3-fluoroamphetamine
Favorite
M0930-08-063 - Development and Characterization of an Antibiotic-Eluting Bone Void Filling (ABVF) Putty for Osteomyelitis Treatment
Favorite
W1030-08-060 - Development and Characterization of Aspirin Loaded Wafers for Buccal and Oral GIT Delivery for Patients with Dysphagia
Favorite
W1230-07-055 - Development and Characterization of Composition-Equivalent Formulations to the One-Month Lupron Depot®
Favorite
T1430-11-086 - Development and Characterization of Composition-Equivalent Formulations to the Sandostatin LAR® by the Solvent Evaporation Method
Favorite
W1230-07-052 - Development and Characterization of Controlled Release Pellets from Aqueous Ethyl Cellulose Dispersions containing Water Soluble/Hydrophilic Plasticizers as Pore-Formers
Favorite
T1430-09-069 - Development and Characterization of Flurbiprofen-Pyrazinamide Cocrystal Formulation as Potential Combination Therapy for Treating Tuberculosis
Favorite
M1230-10-079 - Development and Characterization of In Situ Self-Assembly Nanoparticles for Oral Docetaxel
Favorite
M1430-08-061 - Development and Characterization of Inhalable siRNA Loaded Nanoliposomes
Favorite
M1530-11-084 - Development and Characterization of Liposomes for Treatment of Asthma
Favorite
M0930-07-051 - Development and Characterization of Simulated Gastrointestinal Fluids Representing Patients with Ulcerative Colitis
Favorite
T1130-08-059 - Development and Evaluation of Bone-Targeting Nanoparticle (BTN) as a New Treatment of Bacterial Bone Infections
Favorite
T1330-08-064 - Development and Evaluation of Chemodrug-Loaded Albumin Polymeric Nanocarriers for the Treatment of Neuroblastoma
Favorite
T1430-11-081 - Development and Evaluation of Dry Enteric Coating Approach for Lansoprazole Delayed Release Pellets Using Hypromellose Acetate Succinate (HPMCAS)
Favorite
W1030-10-077 - Development and Optimization of Instanute Coating Formulation containing Calcium Carbonate as an Opacifier
Favorite
T1530-11-083 - Development and Physicochemical Characterization of Protein-Lipid Hybrid Nanoparticles as a Drug Carrier Platform
Favorite
W1030-09-067 - Development and Processing of Spider Silk as a Biopolymer for a Hemocompatible Catheter Coating
Favorite
T1030-07-053 - Development and Validation of a GC-Headspace Method for the Determination and Quantification of Residual Solvents in Transdermal Drug Delivery Systems (TDS)
Favorite
T1530-08-060 - Development and Validation of a HPLC Method for the Analysis of β-caryophyllene and Evaluation of its Potential as a Candidate for Transdermal Drug Delivery
Favorite
M1030-12-091 - Development and Validation of a Rapid GC-FID Method to Simultaneously Determine Triethylamine, Diisopropylamine, and 1,1,3,3-Tetramethylguanidine Residues in an API
Favorite
M1130-13-100 - Development and Validation of an In Vitro In Vivo Correlation (IVIVC) for Oxybutynin Chloride Extended Release Tablets
Favorite
W0930-07-049 - Development and Validation of an Ion Chromatography Method to Determine Zinc Oxide in Sunscreens
Favorite
T1330-09-070 - Development of 3D Printed Tablets by Fused Deposition Modeling for Rapid Drug Release
Favorite
M1130-11-088 - Development of a Generally Applicable Method to Determine the Encapsulation Efficiency of Proteins in Polymer Matrices
Favorite
T1330-07-052 - Development of a Modified Release Tablet Containing an API Prone to Form Changes and Gelling in Aqueous Media
Favorite
W1030-11-088 - Development of a Mucoadhesive Mouthwash: An Integrated Approach to Evaluate the Mucoadhesive Properties
Favorite
M1130-08-058 - Development of a New Nanoemusion System Intended for Targeted Drug Delivery to HIV Lymphocyte Reservoir
Favorite
T1130-12-094 - Development of a Novel Gastro-Floating System for Acyclovir by Using 3D Printing Technology.
Favorite
W0930-11-082 - Development of a Novel Oral Fast-Dissolving Film for Pediatric Use
Favorite
M1230-08-058 - Development of a Novel Sustained Release In Situ Gelling System for the Treatment of Uveal Melanoma
Favorite
M1330-07-054 - Development of a Reverse-Phase HPLC Method for a Pyruvic Acid Derivative in a Semisolid Dosage Form
Favorite
M1330-07-053 - Development of a Robust Qualitative Method Using Near-Infrared Spectroscopy and Support Vector Machine to Monitor Pharmaceutical Product Quality in the Low-Resource Setting
Favorite
T0930-13-103 - Development of a Scientific Framework for Extension of Medication Shelf-Lives beyond Declared Expiration Dates
Favorite
T1230-13-102 - Development of a Semifluorinated Nanoemulsion Platform for Tunable Therapeutic and Diagnostic Delivery
Favorite
W1030-09-068 - Development of a Shell-Core Modified Release Tablet via HME-Coupled 3D Printing for Oral Pulsatile Delivery
Favorite
M1130-11-085 - Development of a Stable Anticancer Formulation of BIO-X1: From Solution to Lyophilized Drug Product
Favorite
T1530-11-082 - Development of a Stable Anticancer Lyophilized Formulation of SMS-IV1 as an Intravenous Infusion
Favorite
W1030-12-094 - Development of a Stable Formulation for Stabilized HIV-1 Env Trimer Vaccine Candidate (HIV-1 Trimer 4571)
Favorite
W1030-12-096 - Development of a Stable High Concentration Formulation for Anti-malaria Antibody CIS43LS
Favorite
T1130-12-091 - Development of a Suspension-Type Transdermal Patch of Tenofovir Alafenamide
Favorite
M1330-11-084 - Development of an Acid Resistant Banding Solution for DRcapsTM
Favorite
W0930-08-057 - Development of an Aqueous Nanoformulation of Cannabidiol (CBD)
Favorite
M1430-07-051 - Development of an Improved Reversed-Phase HPLC Stability Indicating Method and Forced Degradation Studies of Curcuminoids
Favorite
T0930-08-057 - Development of an In Situ Gelling Collagen Drug Formulation
Favorite
M1130-07-053 - Development of an In Vitro Release Rate Test for Loteprednol in an Ophthalmic Suspension Using USP Immersion Cell Apparatus
Favorite
W1230-12-096 - Development of an In-Line Near-Infrared Method for Blend Content Uniformity Assessment in a Tablet Feed Frame
Favorite
T1230-11-086 - Development of Colon-Targeted ProRelease® Microparticle Formulation of a Discovery Candidate for Preclinical Studies
Favorite
M1030-09-072 - Development of Composite Microsphere Loading Doxorubicin Nanoparticle and 20(S)-Ginsenoside Rh2 for Drug Resistance Breast Cancer Treatment
Favorite
T1230-11-085 - Development of Controlled Release Oral Dosages by Density Gradient Modification Using 3D Printing Technologies
Favorite
M1130-09-071 - Development of Core-Shell Structured Controlled Release Oral Dosages Using 3D Printing Technologies
Favorite
W1230-10-079 - Development of Cough Cold Liquids
Favorite
W1130-11-086 - Development of Delayed-Release Pellets of Ibuprofen Using Kollicoat® MAE 100P via Hot-Melt Extrusion Technology
Favorite
M1230-11-088 - Development of Esculetin Nanocrystal: Toward an Innovative Approach for Hyperuricemia
Favorite
M1530-10-079 - Development of Fast Dissolving Film for Intra-Oral Delivery
Favorite
W0930-11-081 - Development of FDC Nanosuspension for Anti-HIV Therapy by Computational and Experimental Approach
Favorite
T1230-11-088 - Development of Floating Pulsatile Delivery System for Chronotherapy of Nocturnal Asthma Using Hot Melt Extrusion Coupled 3D Printing
Favorite
T1030-13-101 - Development of In Vitro Diffusion Method for Nasally Insufflated Abuse Deterrent Formulation
Favorite
T1130-13-097 - Development of In Vitro In Vivo Correlation (IVIVC) for Upadacitinib Extended-Release Formulation
Favorite
M1130-13-099 - Development of In Vitro-In Vivo Correlation for Complex Parenteral Microsphere Drug Products – Effect of Burst Release
Favorite
T1130-13-099 - Development of In Vitro-In Vivo Correlation of Peptide Microspheres – Possibility and Challenges
Favorite
W1230-11-088 - Development of Injectable Intramuscular Particulate Formulation of Anti-infective
Favorite
T1130-08-064 - Development of Insulin Solution Dosage Form for Sublingual Administration Using Design of Experiments Approach
Favorite
T1230-11-081 - Development of Microparticle Using Spray Drying and Emulsion Evaporation Technology for Colon-Targeted Oral Drug Delivery
Favorite
W1130-08-057 - Development of Nanocarriers for Cutaneous Delivery of H 2 S-Releasing Corticosteroids for Psoriasis Treatment
Favorite
T1030-10-076 - Development of Novel D-cycloserine-Loaded Tablet with Improved Drug Stability and Dissolution-Equivalence to the D-cycloserine-Loaded Commercial Hard Capsule
Favorite
M1430-13-098 - Development of Novel Flash Orally Disintegrating Tablet Dosage Forms
Favorite
M1230-08-057 - Development of Novel Ophthalmic Drug Delivery System of Pefloxacin with Increased Ocular Availability
Favorite
W0930-09-071 - Development of Novel Ultra-Long-Acting Injectable Combinatory Implants for Treatment of Osteoporosis
Favorite
M1430-11-086 - Development of Oral Gastro-Retentive Delivery System Using Immediate Floating Tablet Technology
Favorite
M1430-08-063 - Development of Platelet-Inspired Carriers for Targeted Thrombolytic Therapy
Favorite
W1130-07-053 - Development of Prolonged-Release Tablets with Thermoplastic Polyurethanes by Ultrasound Assisted Direct Compression
Favorite
M1230-12-093 - Development of Solid Lipid Nanoparticles using Hot Melt Extrusion for Pulmonary Delivery of Water Insoluble Drugs
Favorite
M1330-07-051 - Development of Stability Indicating RP-HPLC Method for an α-Amino Acid in a Topical Formulation Without Derivatization
Favorite
W1130-11-088 - Development of Stimuli-Responsive Polymersomes for Tumor Drug Delivery
Favorite
T1230-09-068 - Development of Sulfo-albumin as a Macromolecular Hydrogen Sulfide Prodrug for the Treatment of Reactive Oxygen Species-Mediated Disease
Favorite
W1230-09-070 - Development of Surface-Modified High Potency Nanoaggregates of Voriconazole Powders for Dry Powder Inhalation
Favorite
T1130-11-085 - Development of the Multi-layered Organic-Inorganic Hybrid Nanocomplex as an Effective Oral Delivery System of Protein Drugs
Favorite
T1430-12-092 - Development of Theophylline and Nicotinamide Co-crystals Utilizing Hot Melt Extrusion Technology
Favorite
M1530-08-064 - Development of Transdermal Patch of Tenofovir Alafenamide for HIV Prophylaxis and Treatment
Favorite
W1030-11-085 - Diclofenac Sodium Stability in Simulating Physiological Media and Its Entrapment Efficiency in MCM-41
Favorite
T1530-10-074 - Dimethlacetamide and a Novel Co-processed Excipient- A Promising Approach to Develop a Rapid Release Self-nanoemulsifying Tablet of Fenofirbate
Favorite
M0930-07-054 - Discriminating Dissolution Method for a HPMC Capsule Formulation Containing a BCS Class II/IV Compound with the Functional Excipient Tartaric Acid
Favorite
M1430-10-074 - Disintegration Testing of Botanicals (Green Tea and Turmeric) Dietary Supplements (DS): A Dietary Supplement Ingredient Database (DSID) Initiative
Favorite
T1430-09-066 - Dissolution Method Development for Assessing Amorphous Solid Dispersions
Favorite
M0930-07-052 - Dissolution Screening for Formulation to Mitigate PPI or H2-RAs Effect: Synergies of Biorelevant Media and On-Line Dissolution Monitoring
Favorite
M1130-07-049 - Dissolution Testing of Nifedipine ER Tablet Using the USP Flow-Through Method
Favorite
M1130-07-050 - Do All Solid Hydrophilic Carriers Enhance Dissolution Rates? An Investigation into the Relationship between Solid Hydrophilic Carriers and Their Effect on Dissolution Rates
Favorite
M1330-10-076 - DoE Based Systematic Development of Novel Optimized Solid Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) of Berberine with Enhanced Oral Bioavailability for Antihyperlipidemic Activity
Favorite
M1330-07-050 - Dose Content Uniformity Studies of Multi-dose Ophthalmic Suspension Drug Products as a Metric for Supporting the Quality and Equivalence of Complex Formulations
Favorite
M1030-10-073 - Drug Crystallization in Amorphous Solid Dispersions
Favorite
W0930-11-086 - Drug-Drug Ionic Liquids of Diphenhydramine with Ibuprofen and Naproxen–Discovery, Characterization, and Capsule Development
Favorite
W1230-09-071 - Dry Powder Fomulations of Newly-Developed Anti-Tuberculosis Drug Spectinamide 1599
Favorite
M1330-13-101 - Dual Functionalized Chitosan Nanomicelles Mediated Gene Delivery for Targeting Pro-Inflammatory Macrophages for the Treatment of Insulin Resistance
Favorite
W1230-07-054 - Dual-Effect Liposome Encapsulated with Irinotecan and Chlorin e6 to Improve Treatment Outcome of Resistant Pancreatic Cancer Cell Lines
Favorite
T1230-13-101 - Duality of Tumor Microenvironment on Biomimetic Nanoparticles
Favorite
T1230-10-075 - Dynamic Vapor Sorption and Raman Spectroscopy Investigation of Competitive Hydrate-Solvate Formation
Favorite
M1530-13-097 - Effect of Acidic Ternary Salts on Dovitinib/Cyclodextrin Solubilization and Complexation
Favorite
W1230-08-060 - Effect of Choosing Different Pressure Sensitive Adhesives on Performance Parameters of Lidocaine Patches
Favorite
M1030-13-101 - Effect of Co-administration of Foods and Drinks on the Dissolution of Paediatric Formulations–Case Study Mesalazine
Favorite
T1030-13-103 - Effect of Co-administration of Foods and Drinks on the Dissolution of Paediatric Formulations-Case Study Montelukast
Favorite
T1530-07-055 - Effect of Continuous Phase Properties on the Formation of PLGA Microparticles
Favorite
T1430-07-053 - Effect of Copolymer Concentration and Drug Loading on Release Profile of Insulin Incorporated in Thermosensitive Copolymer Based Delivery System
Favorite
M1030-13-100 - Effect of Different Model Compounds on γCD Apparent Critical Aggregation Concentration
Favorite
M1530-08-058 - Effect of Dosing Frequency on In Vitro Permeation of Trolamine Salicylate through Porcine Ear Skin
Favorite
T1130-10-078 - Effect of Drug Crystallization on In Vitro Performance of Testosterone Loaded Transdermal Delivery Systems
Favorite
M0930-10-080 - Effect of Drug Loading on Release from Amorphous Solid Dispersions Based on Water Soluble Polymers
Favorite
W1130-13-100 - Effect of Excipients on Physical Stability and Aerosol Performance of Spray Dried Amorphous DPI Formulations
Favorite
M1130-09-065 - Effect of Formulation Composition of Drug-Loaded Microemulsions on the Skin Retention and Permeation Through Microneedle Pretreated Skin
Favorite
T1530-09-067 - Effect of Formulation on the Disintegration of Spray-Dried Dispersion (SDD) and Co-Processed Intermediate (CPI) Tablets
Favorite
W1230-09-069 - Effect of Formulation Variables on Nasal Permeation and Stability of Naloxone in IItranasal Formulations
Favorite
T1230-07-052 - Effect of Hydroxypropyl-β-cyclodextrin on Dissolution and Flux of Poorly Soluble Drugs Using MacroFLUX
Favorite
T0930-08-061 - Effect of Implant Formation on Drug Release of In Situ Forming Implants
Favorite
T1130-07-053 - Effect of Manufacturing Process on Particle Morphology in Propofol Emulsions
Favorite
M1530-13-101 - Effect of Moisture and Temperature on Physical Stability of Amorphous Solid Dispersion
Favorite
M1030-10-078 - Effect of Particle Size and Polymer Loading on Dissolution Behavior of Amorphous Griseofulvin Powder
Favorite
T1330-07-056 - Effect of Particle Size and Size Distribution on Interfacial Properties of Liposomal Suspensions
Favorite
M1230-10-078 - Effect of Penetration Enhancers on Sublingual Permeability of Epinephrine
Favorite
T1130-07-055 - Effect of Physical and Chemical Factors on Transmission Terahertz Based Density Model
Favorite
M1130-11-082 - Effect of Relative Humidity on the Surface Energetics of Albumins
Favorite
T1030-13-098 - Effect of Simulated Gastrointestinal Contraction on Drug Release of Nifedipine Extended-Release Tablet
Favorite
M0930-11-087 - Effect of Surface Morphology on Very Low Dose API Mixing
Favorite
T1330-09-065 - Effect of Surfactant Level on Properties of Celecoxib Amorphous Solid Dispersion
Favorite
T0930-09-070 - Effect of the Ovalbumin after Transcutaneous Immunization by Dissolving Microneedle Arrays
Favorite
M0930-12-096 - Effect of Trisodium Citrate on the In Vitro Intestinal Permeability of Nutraceuticals
Favorite
M1230-10-073 - Effect of Various Polymers on Solubility and Dissolution Profiles of Mefenamic Acid via Hot-Melt Extrusion Technology
Favorite
M1430-12-089 - Effective Development and Validation of Dilution, Infusion, and In-Use Stability Studies of Pharmaceutical Drug Products
Favorite
M1230-08-060 - Effective Modulation of P-gp Activity in the Blood Ocular Barriers by Topically Administered Specific Inhibitors Improved Blood-Ocular Penetration of Anticancer Drug
Favorite
W0930-13-097 - Effects of Capsule Type on Water Content on a Model Compound
Favorite
T1430-07-055 - Effects of Drug Particle Size and Lipid Additives on the Melt Viscosity and Degree of Surface Drug Coating by Paraffin Wax in Spray Congealing
Favorite
M1330-11-085 - Effects of Drug-Polymer Interactions on Tablet Properties During the Development of Polyethylene oxide Containing Abuse-Deterrent Dosage Forms
Favorite
M1430-08-062 - Effects of Lyophilization and Nebulization on Stability of Single-Chain Tissue-Type and Single-Chain Urokinase Plasminogen Activator for Treatment of Inhalational Smoke-Induced Acute Lung Injury
Favorite
T1530-10-078 - Effects of Medium Chain Mono/Diglycerides on MDCK Cell Viability and Transport of Lipid Nanodroplets across MDCK Cell Monolayers
Favorite
T1530-10-075 - Effects of Molecularly Interacting Additives on Polymeric Hot Melt Extrusion
Favorite
W0930-13-099 - Effects of pH, Temperature and Storage Time on Susceptibility to Glass Particulates of Glass Vial: A Digital Microscopy Study
Favorite
T1030-11-087 - Effects of Solvents and Penetration Enhancers on Transdermal Delivery and Skin Deposition of Thymoquinone, an Anti-inflammatory Phytochemical
Favorite
T1330-13-104 - Efficient and Specific In Vivo Transfection of Neuronal Cells Mediated by Transferrin and Cell-Penetrating Modified Liposomes
Favorite
T1030-12-092 - Efficient Delivery of Paclitaxel for Therapy of Pancreatic Cancer
Favorite
T1330-10-079 - Efficient Drug Solubility Enhancement by Using Ultra-Low Molecular Weight HPC
Favorite
T1030-08-063 - EGF/Lysozyme Loaded Niosomes: A Potential Topical Therapy for Diabetic Foot Ulcer
Favorite
T0930-09-067 - Electrospun Chitosan/Polyethylene Oxide Nanofibers for Oromucosal Drug Delivery
Favorite
T0930-11-088 - Encapsulation of a Novel Silver Complex of Furosemide in Chitosan Nanoparticles for the Enhancement of Antibacterial Activity
Favorite
T0930-12-091 - Encapsulation of Berberine into Monoolein-Based Liquid Crystalline Nanoparticle Dispersion for Enhancement of Anticancer Activity
Favorite
T1330-08-059 - Encapsulation of Furosemide Silver Complex into Nanoparticles to Enhance Antibacterial Activity
Favorite
M1130-08-059 - Encapsulation of Resveratrol-Cyclodextrin Complex Loaded Nanoparticles for Enhanced Anticancer Effects on Non-Small Cell Lung Cancer Cell Lines
Favorite
T1430-08-057 - Endogenous Albumin-Mediated Delivery of Redox-Responsive Micelles for Targeted Cancer Therapy
Favorite
M1130-08-062 - Enhanced Bioavailability of Itraconazole by Two Different Methods of Solid Dispersions
Favorite
M1230-11-084 - Enhanced Dissolution Rate and Bioavailability of Poorly Water Soluble Fenofibrate Formulations by Melt-Adsorption Using Supercritical Carbon Dioxide
Favorite
T1330-11-083 - Enhanced Intra Tablet Enteric Coating Uniformity in the ConsiGma Coating Process
Favorite
M1330-09-069 - Enhanced Irbesartan Solubility through a Co-amorphous Formulation with Glimepiride
Favorite
T1330-08-058 - Enhanced Mucoadhesiveness and Thus Efficacy against Cervical Cancer by Cationic Functionalization of Imatinib Nanocrystals
Favorite
M1430-08-064 - Enhanced Permeation of Lipid-Core Micelles Printed on Mucoadhesive Films to Deliver Biologics through the Buccal Route
Favorite
T1230-09-065 - Enhancement of Aqueous Solubility, Dissolution and Permeability of Lurasidone Hydrochloride via Phospholipid Complexation
Favorite
M1530-11-085 - Enhancement of Gene Transfection Efficiency by the Use of Cell-Targeting Lipid Bubbles and Ultrasound
Favorite
M1530-10-078 - Enhancing Bioavailability of Abiraterone through Use of KinetiSol® Technology
Favorite
T1530-12-096 - Enteric Solid Dosage Formulation for Physiologically Active Proteins and Peptides
Favorite
T1430-12-096 - Enzymatic Site-Selective PEGylation of Proteins at Lysine or Glutamine by Transglutaminase
Favorite
T1130-08-060 - Enzyme Triggered Release of Entry Inhibitor for STD Prevention
Favorite
T0930-12-096 - EphA2 Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAF V600E Mutated Parent and Resistant Melanoma Cancer
Favorite
T1530-12-093 - Establishment of In Vitro and In Vivo Correlation (IVIVC) Modeling Approach for Drugs with Narrow Absorption Window
Favorite
T0930-07-055 - Estimating Aggregate Concentration Precision in Nanoparticle Tracking
Favorite
M0930-07-056 - Estimating Intrinsic Solubility of Metastable Form of Drugs Using Modified Nogami Method
Favorite
T1030-12-091 - Etoposide Loaded Injectable Silk Gels for Local Treatment of Neuroblastoma
Favorite
W1030-13-101 - Eudragit-Based Microprecipitated Bulk Powder Formulations for Enhancing Oral Bioavailability of Sorafenib
Favorite
M1430-13-097 - Evaluating Disintegration Mechanisms that Improve Bioavailability from Immediate Release Tablets Using FBRM
Favorite
W1030-12-089 - Evaluating the Role of the Critical Micelle Concentration of Polysorbate-80 on Visible Particulate Formation after Agitation Stress
Favorite
W1230-13-104 - Evaluating the Stability of Polyvinyl Acetate Dispersion Coated Multi-Particulate Drug Delivery System
Favorite
T0930-11-086 - Evaluation and Optimization of a Topical Suspension Formulation
Favorite
T1030-07-050 - Evaluation and Prevention of an Unknown Impurity On-Column Formation in HPLC Impurity Analysis of an Active Pharmaceutical Ingredient
Favorite
M0930-11-084 - Evaluation of a Developmental High Productivity and High Gloss Film Coating System on the Final Appearance of Coated Tablets
Favorite
M1230-13-101 - Evaluation of a Gelatin-Doxorubicin Conjugate as an Agent of Lysosomal Membrane Permeabilization (LMP) in Breast Cancer Cells
Favorite
M1330-12-090 - Evaluation of an Ultra-High Speed High Gloss Film Coating System in the GEA ConsiGma™ Coater
Favorite
T0930-07-056 - Evaluation of Backgrounded Membrane Imaging (BMI) for iIs Application in the High-Throughput Analysis of Subvisible Particles
Favorite
M0930-13-098 - Evaluation of Bioavailability of Lidocaine and Prilocaine from Topical Drug Products Using an In Vitro Permeation Test (IVPT)
Favorite
M1230-09-068 - Evaluation of Biomimetic Ultra Thin Large Area Polydimethyl Siloxane Membranes in a Rationally Designed In Vivo Relevant Dissolution Apparatus
Favorite
T1230-10-078 - Evaluation of Chemical Stability of Naloxone Products beyond Their Labeled Expiration Dates
Favorite
T1430-10-078 - Evaluation of Coating Performance of Instacoat 4G™ on Tramadol Tablets in an Autocoater
Favorite
M1330-09-072 - Evaluation of Compound A Amorphous Solid Dispersion Dissolution in Biorelevant Dissolution Media
Favorite
W1130-10-074 - Evaluation of Cytotoxicity of Self-Emulsifying Formulations containing Long Chain Lipids Using Caco-2 Cell Model
Favorite
M1030-10-075 - Evaluation of HPMCAS-Nifedipine Solid Dispersion by DSC, XRD and Their Hyphenated Analysis DSC-XRD
Favorite
W1230-07-053 - Evaluation of Hydrogenated Castor Oil for a Controlled Release Multiparticulate Formulation Platform
Favorite
W1030-10-076 - Evaluation of Instacoat™ SFC ( Sugar Fast Coat) in an Autocoater
Favorite
T1530-11-087 - Evaluation of Instacoat™ SFC on Enzyme Tablets Using a Conventional Coating Pan
Favorite
M1230-12-091 - Evaluation of Intra-lysosomal Drug Release from a Gelatin-Doxorubicin Conjugate in MCF-7 Breast Cancer Cells
Favorite
T1330-10-080 - Evaluation of Oleic Acid and Polyethylene Glycol Monomethyl Ether Derivative as a Solubility Enhancer of Furosemide
Favorite
T1430-08-060 - Evaluation of Poly D, L Lactic Co-Glycolic Acid (PLGA) Nanoparticles Uptake Pathways across the Nasal Mucosa
Favorite
M1430-09-071 - Evaluation of Screening Tool for Amorphous Solid Dispersions Prepared Using EUDRAGIT® Polymers
Favorite
M0930-11-081 - Evaluation of Stabilization Effect of HPβCD and PVP on Bovine Serum Albumin (BSA) Spray-Dried (SDD) Formulation
Favorite
M1030-11-083 - Evaluation of Stabilization Effect of HPβCD, PVP, and NaCMC on Bovine Serum Albumin (BSA) Lyophilization Formulation
Favorite
M1030-13-099 - Evaluation of Sub-visible and Nano Particles Originating from Elastomeric Closures
Favorite
T1530-13-102 - Evaluation of the Internal and External Structure of Directly Compressed Polyethylene Oxide (PEO) Based Matrix Tablets Before and after Curing Using X-ray Micro-computed Tomography
Favorite
T0930-10-080 - Evaluation of the Sublingual pH-Permeability Profile of Epinephrine
Favorite
M1030-09-067 - Evaluation of Topical Pilocarpine Formulation for Stimulating Sweat Secretion for Cystic Fibrosis Diagnosis
Favorite
W1130-10-077 - Evaluation the Bitterness Masking Effect of Umami Peptides on Bitter Drugs by Taste Sensor Measurement and Human Sensation Test
Favorite
W1030-09-071 - Evaluations of Ease of Swallowing and Handling Tablets of Various Sizes in Healthy Volunteers and Elderly Patients
Favorite
W1130-10-079 - Excipient Consistency Is Key to De-risk Formulation Development and Manufacturing
Favorite
M1330-13-100 - Excipient Screening for the Protection of ABAB Antibody producing Saccharomyces boulardii for the Treatment of Clostridium Difficile Infection (CDI) during Spray Drying
Favorite
T1430-11-084 - Experimental Design Approach for Optimization of Monodisperse Polymeric Microparticles Using Modified Vibrating Orifice Aerosol Generator for Controlled Delivery of Letrozole in Breast Cancer Therapy
Favorite
M1230-07-051 - Exploring the Impact of Excipients on Formulation Properties Through Quality by Design
Favorite
M1230-08-064 - Extended Release of Protein to the Ocular Surface
Favorite
T1530-08-063 - Extractable Evaluation on Microneedle Patches
Favorite
W0930-13-103 - Extractable Study of Westar® Chlorobutyl Rubber Stopper
Favorite
T1330-11-082 - Extrudability Analysis of Drug Loaded Pastes for 3D Printing of Modified Release Tablets
Favorite
W1030-09-066 - Fabrication and Characterization of Controlled Release PLGA Microneedle for In Situ Prolonged Delivery of FITC-Dextran
Favorite
M1230-12-089 - Fabrication of Metformin Loaded PLGA Microparticles Using Double Emulsion Solvent Evaporation Method: A Design of Experiment Study
Favorite
T1030-09-067 - Fabrication of Novel PLGA Nanoparticles for Anticancer Peptide Delivery
Favorite
W0930-08-064 - Fabrication, Evaluation and Antioxidant Activity of Caffeine Fast Melt Tablets
Favorite
M1130-11-083 - Factors Governing the Reconstitution Time of Highly Concentrated Lyophilized Proteins in Amorphous Formulations
Favorite
T1030-09-072 - Fate of Biodegradable Microneedles In Vivo – A Mechanistic Insight
Favorite
W1130-10-078 - Feasibility of High-Dose OD Tablets Containing API which has Low Compressibility
Favorite
T1030-12-093 - Finding the Right Fit: Comparison of In Vitro and In Vivo Performance of Different Modified Release Formulation Platforms
Favorite
M1130-12-091 - FKBP Elastin Like-Polypeptide Fusion Carriers Facilitate Intracellular Delivery of Rapamycin by Macropinocytosis
Favorite
T0930-07-054 - Flow-Imaging Microscopy Goes Submicron – A Feasibility Study with Relevant Biopharmaceutical Drug Products
Favorite
T1130-11-086 - Fluorescence and Light Scatter Distinguish Different Degrees of Perturbations in Proteins
Favorite
M1530-07-050 - Focused Ion Beam Etching as a Technique for Submicron-Imaging of Lipid Multiparticulates
Favorite
T1130-09-072 - Formulating Extended Release Drug Pellets Using CPS™ Technology
Favorite
W1030-09-072 - Formulation and Characterisation of Metronidazole Buccal films
Favorite
T0930-12-090 - Formulation and Characterization of Albumin/Glycine Microspheres Encapsulated with Resveratrol as a Model Drug
Favorite
W1230-11-087 - Formulation and Characterization of Curcumin Loaded Polymeric Micelles Produced via Continuous Processing Using Co-Axial Jet in Co-flow Technology
Favorite
W0930-12-092 - Formulation and Characterization of Nanoparticles for Poorly Soluble Compounds against Cataract and Assessment of Their Antioxidant Activity by Chemical and Biochemical Assays
Favorite
W1130-13-101 - Formulation and Characterization of Spray Dried Pyrazinoic Acid Dry Powder toward Inhaled Therapies of Tuberculosis
Favorite
M1530-08-060 - Formulation and Evaluation of 4-benzylpiperidine Drug-in-Adhesive Matrix Type Transdermal Patch
Favorite
T1030-11-081 - Formulation and In Vitro Evaluation of a New Mucoadhesive Mouthwash
Favorite
M1330-10-077 - Formulation and In vitro Evaluation of Dronedarone HCl Ternary Mixture Formulations
Favorite
T1330-13-100 - Formulation and In Vitro Evaluation of Spray-Dried Hydrogel Containing Sildenafil Citrate for Pulmonary Drug Delivery
Favorite
T1530-13-098 - Formulation and Optimization of Oil/PEG Cream by Hot Melt Extrusion Technology
Favorite
W1030-07-053 - Formulation and Pharmacokinetics of Multi-layered Matrix Tablets: Biphasic Delivery of Diclofenac
Favorite
M0930-11-082 - Formulation and Stability of Lysozyme
Favorite
M1030-11-084 - Formulation Design Space Assessment for a Humanized IgG1 Monoclonal Antibody
Favorite
M1330-10-079 - Formulation Development and Evaluation of Ticagrelor Loaded Self-emulsifying Drug Delivery System (SMEDDS)
Favorite
T1230-08-057 - Formulation Development and In Vitro Characterization of Axitinib Loaded Polylactic-co-Glycolic Acid (PLGA) Nanoparticles
Favorite
T1330-11-084 - Formulation Development and Pharmacokinetics of OJT001 Loaded Solid Lipid Nanoparticles
Favorite
M1130-12-090 - Formulation Development, cGMP Manufacturing and Characterization of a Novel Transdermal Formulation for E/Z-Endoxifen
Favorite
T1130-12-092 - Formulation of a Hydroxypropyl Methylcellulose Gel Embeded with Nicotine Conjugate Loaded Solid Lipid Nanoparticles and Its Evaluation as a Transdermal Delivery System
Favorite
T0930-10-078 - Formulation of Aripiprazole-Loaded pH-Modulated Solid Dispersions via Hot-Melt Extrusion Technology: In Vitro and In Vivo Studies
Favorite
W1230-09-067 - Formulation of Gefitinib Loaded Nanostructured Lipid Carriers (NLC): Methods to Improve Drug Loading into the Lipid Core of NLC’s
Favorite
M1130-10-075 - Formulation of HPMCAS-based Solid Dispersions Prepared by Hot-Melt Extrusion: Polymer-Drug-Surfactant Miscibility, Extrudability, and Effect of Surfactants on Drug Release
Favorite
T0930-11-082 - Formulation of Lipid Based Tableted Spray-Congealed Microparticles for Zero Order Release of Vildagliptin
Favorite
W0930-11-085 - Formulation of Rapidly Disintegrating Tablets with High Bitter Drug Load and High Tensile Strength
Favorite
T1530-11-088 - Formulation of ST-001 Nanosuspension
Favorite
T1230-09-072 - Formulation of Tadalafil Loaded PLGA Nanoparticles for Non-Invasive Pulmonary Delivery
Favorite
T1230-08-061 - Formulation Optimization and Ocular Pharmacokinetics and Toxicity Investigations of Insulin-Loaded Thermoresponsive Biodegradable Nanogels Intended for the Treatment of Diabetic Retinopathy
Favorite
M1030-08-063 - Formulation Optimization of BDNF siRNA Loaded Lipidoid-Nanoparticles for Chronic Pain Therapy
Favorite
T1330-13-101 - Formulation Optimization of Spray-Freeze Dried Sildenafil Citrate Large Porous Microparticles for Pulmonary Drug Delivery
Favorite
M0930-11-085 - Formulation, Rheological and Mechanical Characterization of Soluplus®/Vitamin E Blends
Favorite
W1130-09-067 - F-Protein Virus Like Particle Microparticulate Vaccine for RSV Infection: In Vitro and In Vivo Immunogenicity Evaluation
Favorite
T0930-13-099 - Frequently Observed Deficiencies in Abbreviated New Drug Applications (ANDAs) Related to Analytical Method Validation/Verification/Transfer
Favorite
M0930-13-102 - Frequently Observed Deficiencies in Refuse-to-Receive Abbreviated New Drug Applications
Favorite
M1030-07-053 - Functional Characterization of Excipients Used in Solid Oral Dosage Forms by UV-Vis Dissolution Imaging
Favorite
T1430-11-082 - Gastric Gloating Drug Delivery Systems of Metoprolol Succinate Using Non Effervescent and Effervescent Approaches - Design and Biopharmaceutical Evaluation
Favorite
M1430-10-078 - Gelucire 48/16®: A Versatile Non-Ionic Solid Solubilizer for Tablets of Poorly Water-Soluble Drugs
Favorite
M1230-13-104 - Gene Delivery through GLUT-1 and Penetratin Targeted Nanoparticles to Brain: In Vitro Characterization for Particles Size, Charge, Cell Uptake and Transfection Efficiency
Favorite
M1330-09-067 - Hansen Solubility Parameters as Predictors of Miscibility in Amorphous Solid Dispersions
Favorite
T1030-08-064 - Harnessing Fibroblast Growth Factor-Inducible 14 (Fn14) for Targeting Metastatic Triple Negative Breast Cancer
Favorite
M1030-08-062 - Hemopressin-Based pH-Sensitive Hydrogel: A Potential Bioactive Platform for Drug Delivery
Favorite
T1530-07-053 - High Diffusivity Peptides as Drug Carriers through Tumor Extracellular Matrix
Favorite
T1530-07-052 - High Intensity Focused Ultrasound (HIFU)-Triggered Liposomal Drug Release Using Acoustic Cavitation Effect
Favorite
M1130-07-056 - High Levels of Acidic Variants Caused by Carbonylation in Manufactured Monoclonal Antibody Batches
Favorite
T1530-09-066 - High Loaded Amorphous Nanoparticles for Delivery of Very Low Solubility Compounds
Favorite
T1130-09-071 - High Pressure Homogenization as a Potential Approach to Formulate Amodiaquine Nanoparticles and Exploring Their Efficacy in Non-Small Cell Lung Cancer
Favorite
W0930-10-079 - High Solids Loading in HPMCAS Spray Dry Solutions and Effects on Solid Dispersion Morphology
Favorite
W0930-07-056 - High Temperature Measurement of API Solubility in Organic Solvents for Spray-Drying Process Development
Favorite
T1030-11-083 - High Throughput Screening and Chemical Sparing Approach To Emulsion Formulation Development through Acoustic Mixing
Favorite
M1530-10-075 - High Throughput Screening for the Discovery of Self-Emulsifying Drug Delivery Systems (SEDDS)
Favorite
M1430-12-093 - High-Efficiency Method to Load Protein Drugs into Exosome while Keeping Innate Exosome Properties
Favorite
T1130-13-101 - Highlights of Biopharmaceutics Review Good Practices for Setting Clinically Relevant Specifications for Drug Substance’s Particle Size, based on PBPK Absorption Modeling and Simulation
Favorite
T1230-13-100 - Highly Porous Bilayer Tablets for Enhanced Gastroretentive Properties and Easy Formulation Development.
Favorite
W0930-12-096 - High-Throughput Formulation Screening to Study Skin Retention Using Two-Photon Microscopy
Favorite
W0930-11-084 - Hot-Melt Co-extrusion Technology as a Manufacturing Platform for Anti-hypertensive Fixed-Dose Combinations
Favorite
T1330-13-103 - How Does the Presence of Particles affect the Plume Characteristics of Nasal Sprays?
Favorite
M1530-09-072 - How Drug Solubilizing Agents Modulate Cocrystal Supersaturation Index and Manage Phase Transformations
Favorite
W0930-12-089 - Hydrophobic Impurities Cause Measurable Changes in the Physico-Chemical Behavior of Poloxamer 188
Favorite
T1130-10-080 - Ibuprofen/Microcrystalline Cellulose Percolation Threshold - Impact on Tablet Dissolution Process
Favorite
M1130-12-095 - Identification and Optimization of Critical Process Parameters of Roller Compacted Capsules: from Development to Registration Batches
Favorite
T0930-07-049 - Identification and Quantitation of Residual Monomers in PLGA Copolymers
Favorite
T1130-11-087 - Identification of Drug Substance Charge Variants of a Monoclonal Antibody Involved in Aggregation Formation
Favorite
M1130-13-097 - Identification of the Potential Culprits of Adverse Effects for Warfarin Generic Products Using PBPK/PD Modeling Approach
Favorite
T1130-07-050 - Identify Your Limits: Definition of Spray Drying Tout Based on a Novel Methodology to Measure Powder Stickiness
Favorite
W0930-08-062 - Imaging-Guided Targeted Drug Delivery Using Stimuli-Sensitive Theranostic Nanoparticles: Characterization and In Vivo Trafficking Patterns
Favorite
T1130-10-076 - Impact of Acetaminophen Crystal Size on In Vitro Performance of METHOCEL Premium DC2 HPMC Matrix Tablets
Favorite
T1430-10-077 - Impact of Excipients Commonly Used in Lipid-Based Drug Delivery Systems on Softgels Performance
Favorite
M1430-09-069 - Impact of Formulation Parameters on Tablets Containing a High Level of Amorphous Solid Dispersion Prepared by Hot Melt Extrusion
Favorite
W1030-11-084 - Impact of Hydroxyl Value of Fatty Acid Based Suppository on Condom Compatibility
Favorite
M1130-10-076 - Impact of Method of Preparation on the Morphology and Mechanical Properties of Amorphous Solid Dispersion: Comparison of Co-precipitation and Spray Drying
Favorite
M0930-10-079 - Impact of Microstructure on the Dissolution Performance of Amorphous Solid Dispersions
Favorite
W1030-12-092 - Impact of Processing Conditions and an Amorphous Co-solute on the Phase Behaviors of Poloxamer 188 Aqueous Solutions during Freezing and Thawing
Favorite
M0930-10-077 - Impact of Temperature Relative to the Glass Transition Temperature on the Dissolution Performance of Anacetrapib-Copovidone Amorphous Solid Dispersions
Favorite
M1130-10-079 - Impacts of Polymers on Crystal Nucleation and Growth of Indomethacin from Supersaturated Solutions
Favorite
T1430-10-073 - Improved Functional Properties of Fine Excipients and Blends via Dry Coating with Nano-Particles
Favorite
T1530-11-086 - Improved Palatability of Gummi Drug of Epinastine Hydrochloride Using Organoleptic Taste-Masking Methods
Favorite
M0930-11-086 - Improved Plasdone S630: A New Grade of Copovidone with Enhanced Properties for Hot Melt Extrusion (HME) Process
Favorite
W1030-12-095 - Improved Understanding of Protein Interactions in Formulation Development Using Liquid Cell Electron Microscopy
Favorite
W0930-13-100 - Improvement of Extraction Efficiency and Quantification Accuracy for the Analysis of Volatile Organic Compounds Extracted from Pharmaceutical Contact Materials
Favorite
M1430-07-049 - Improvement of HPLC Method Parameters to Solve an Antibiotic Analog Compound Anomalous Behavior
Favorite
M1330-09-070 - Improving Bioavailability by Co-crystal Formation: An Aprepitant Story
Favorite
M1330-11-088 - Improving Hydrophilic Drug Loading and Dissolution Rate of 3D Printed PVA Based Tablets
Favorite
M1030-11-082 - In Silico Discovery of Potential Excipients for Novel Antibodies
Favorite
M1030-07-052 - In Situ Fiber Optic Dissolution Monitoring of Combination Drug Product Containing Three Actives
Favorite
T1230-07-056 - In Situ Mechanical Raman Spectroscopy for Monitoring of Chlorpropamide Polymorphic Transformation during Tableting
Favorite
M1230-10-080 - In Vitro Evaluation of Nanocrystals for Enhancing Bioavailability of a P-glycoprotien Substrate Drug as Atorvastatin Calcium
Favorite
M1130-09-068 - In Vitro and In Vivo Evaluation of Two Lidocaine Topical Delivery Systems With or Without the Influence of Transient Heat Exposure
Favorite
T1330-12-096 - In Vitro Assessment of Natural Products in Murine Macrophages for the Treatment of Chronic Inflammation
Favorite
M1530-08-062 - In Vitro Dermatokinetic of Silymarin in Human Skin Models
Favorite
M1030-07-051 - In Vitro Dissolution and In Silico Simulation to Evaluate Intestinal Precipitation and Supersaturation of a Weakly Basic Pharmaceutical Compound
Favorite
M1530-09-070 - In Vitro Dissolution Investigations of Novel Solid Dispersions Using Sodium Alginate, Surfactants and a BCS IV Drug
Favorite
M1530-10-080 - In Vitro Dissolution-Permeation Study to Characterize Itraconazole Formulations: The Effect of Formulation Additives, Food and Dose
Favorite
W1130-09-069 - In Vitro Evaluation of Porin Encapsulated Chitosan Nanosystems for Mucosal Vaccine Delivery
Favorite
M1130-09-069 - In Vitro Permeation Behaviour of a Novel Tyrosinase Inhibitor Investigated by Human Skin, Porcine Skin, and an Artificial Skin Model
Favorite
M1030-09-071 - In Vitro Permeation Testing to Evaluate the Combined Permeation Efficiency of Immediate and Delayed Application of Two Topical Ointment Formulations for the Treatment of Psoriasis
Favorite
W1030-07-051 - In Vitro Release and Pharmacokinetics of Mebeverine HCl Floating Delivery Systems in Beagle Dogs
Favorite
M1230-07-049 - In Vitro Release Test (IVRT) Comparisons of Six Acyclovir Cream, 5% Products to Evaluate the Impact of Compositional Differences on Product Performance
Favorite
M1130-07-054 - In Vitro Release Testing Method Development for In Situ Forming Gels
Favorite
W1130-13-104 - In Vitro Release Testing Methods for Long-Acting Intrauterine Systems
Favorite
T0930-10-075 - In Vivo Evaluation of a Cefuroxime Axetil Gastro-Retentive Floating Drug Delivery System Prepared by Hot-Melt Extrusion Technology
Favorite
M1030-11-087 - In Vivo Evaluation of Lipid Coated Magnesium Phosphate Nanoparticles for Intracellular Protein Delivery
Favorite
W1130-13-099 - Incorporation of Colistin in the Spray Dried Ciprofloxacin Improves Physical and Aerosolization Stability of Dry Powder Inhaler Formulations
Favorite
T1530-11-085 - Incorporation of Lipophilicity to Proteins and Peptides
Favorite
T1130-09-069 - Increased Intracellular Uptake of Serum Albumin Nanoparticles in Oncogenic KRAS Cancer Cells
Favorite
T1030-09-071 - Increasing Therapeutic Potency of Extracellular Vesicles via Novel Loading Mechanisms
Favorite
W0930-09-070 - Indocyaine Green-Chitosan Nanoparticles-Loaded Dissolving Microneedles for Melanoma Photothemal Therapy
Favorite
M1530-12-093 - Influence of Anti-static Agent Addition on the Excipient Powders Behavior
Favorite
T1430-13-101 - Influence of Geometry on the Drug Release Profiles of Stereolithographic (SLA) 3D Printed Tablets
Favorite
M1330-10-078 - Influence of HPMC and SLS on the Solubility and Dissolution of Sirolimus in Solvent-Evaporated Solid Dispersions
Favorite
M1430-11-087 - Influence of Kollicoat MAE 100-55, a Novel Polymer for Taste Masking via Hot Melt Extrusion Technology: Impact of Pore Formers
Favorite
T1430-09-068 - Influence of Mechanical and Thermal Energies on Nifedipine Amorphous Solid Dispersion Prepared by Hot Melt Extrusion
Favorite
M1230-10-074 - Influence of Mesoporous Silica Properties on Drug Loading Capacity
Favorite
T1430-10-079 - Influence of Micronized HPC on Dynamic Powder Flow
Favorite
M1330-11-086 - Influence of Processing Variables on Solid-State Stability and Dissolution of Phenytoin Sodium Extended Release Capsule
Favorite
W1230-11-086 - Influence of Sulfobutylether-β-Cyclodextrin on Intravenous Pharmacokinetics of Silymarin
Favorite
M0930-12-089 - Influence of the Adsorbent Types on the Dissolution of Poorly Water Soluble Drug Cinnarizine from Lipid-Based Self-emulsifying Formulations
Favorite
W1130-13-097 - Inhalation Delivery of Bio-inspired Tofacitinib Loaded Liposomes: Formulation and evaluation
Favorite
M1030-09-065 - Inhibition of Anandamide Metabolism in In Vitro Human Skin Model
Favorite
T1530-07-051 - Injectable Poly(lactic-co-glycolic acid) Microspheres for One-month Controlled Release of Etonogestrel
Favorite
T1130-09-065 - Injectable Self-Healing Gel with Controlled VEGF Release for Induced Angiogenesis
Favorite
T1530-13-099 - Inkjet-Based 3D Printing of Solid Oral Dosage Manufacturing
Favorite
T1130-10-075 - Inline Raman Monitoring and Analysis of Carbamazepine Polymorphic Form Transformation Using Twin Screw Extrusion (TSE) Platform
Favorite
W1130-09-070 - Insoluble Aluminum Salt-Adjuvanted Vaccine Dry Powder Prepared by Thin-Film Freeze-Drying is Suitable for Intranasal Administration
Favorite
M1330-07-052 - Interactions of Solubilizer, Formulation pH and Preservative: A Case Study of Pediatric Oral Solution Formulation Stability
Favorite
T1330-10-078 - Introduction of CREA-IM as Anti-segregation Agent for Levothyroxine
Favorite
M1230-12-095 - In-Use Stability for a Drug/Device Combination of Solid Multiparticulates for Oral Delivery to the Pediatric Population
Favorite
M1530-08-059 - Investigate the Impact of Homogenization as a Scale up factor on Rheological properties from Hydroxypropyl cellulose Topical gel
Favorite
M1130-09-066 - Investigating Drug Loading Capacity of TyroSpheres, a Polymer-Based Nanocarrier System for Use in Dermal Delivery
Favorite
M1030-13-103 - Investigating Factors That Affect In Vitro Drug Release From A Parenteral Liposomal Formulation
Favorite
T1530-09-072 - Investigating the Applicability of the Molecular Descriptor R3m in Predicting Amorphous Solid Dispersion formation in Different Polymers
Favorite
W1230-10-074 - Investigating the Effect of Processing Magnesium Stearate on Indomethacin Tablet Dissolution
Favorite
T1330-10-077 - Investigating the Impact of Extruder Process Parameters and Rotation Mode on HPMCAS Degradation
Favorite
W1030-12-090 - Investigating the Influence of Polysorbate 20/80 and Polaxomer P188 On Bovine Serum Albumin and Lysozyme Aggregation, Rheology & Interfacial Properties
Favorite
T1330-09-069 - Investigating the Relationship between the Molecular Descriptor R3m and API-Polymer Miscibility
Favorite
T1030-13-097 - Investigating the Solubility of Poorly Soluble Compounds in Biorelevant Media Simulating Patients with Ulcerative Colitis
Favorite
T1430-13-100 - Investigation into the Internal Structure of Coated Microparticles to Support Formulation and Coating Process Development
Favorite
M0930-07-049 - Investigation of a Small Volume Dissolution Method to Simulate Mouth Cavity Condition for Taste-Masking Evaluation of Dextromethorphan - Resin Complex
Favorite
M1230-07-052 - Investigation of Excipient Variability on Dissolution of a Highly Soluble Compound from Immediate Release Formulations
Favorite
M1030-12-095 - Investigation of Intrinsic Dissolution Rate (IDR) of a Free Base and Salt Form as a Function of pH to Study Salt Disproportionation Risk via Surface Dissolution UV-Imaging System
Favorite
W0930-09-069 - Investigation of Ligand Size on Targeted PLGA Nanoparticles for HER2 Breast Cancer: Whole Anti-HER2 Antibody and Its ScFv
Favorite
M1230-11-083 - Investigation of MCC and HPMC on Drug Dissolution of Tablet Prepared by Direct Compression
Favorite
W1230-13-100 - Investigation of Optimum Coating Conditions for an Easy Swallow Coating System
Favorite
M1430-09-068 - Investigation of Photostability of Curcumin via Cocrystallization with Polyphenols
Favorite
M1130-10-078 - Investigation of Polymer-Assisted Pharmaceutical Cocrystals Produced via Hot Melt Extrusion Technology
Favorite
M1530-12-094 - Investigation of Polyox Aqueous Granulation Using Fluid Bed Processor- Top Spray Method
Favorite
T1430-08-062 - Investigation of the Effect of Injection Rate and Performance While Injecting Highly Viscous Polymeric Fluids Mimicking Concentrated Biopharmaceuticals into Tissues
Favorite
T1230-10-079 - Investigation of the Physical Properties of Drug-Excipient Tablets Comprising Powders Produced by Co-Spray Drying
Favorite
W0930-13-098 - Investigation On Opalescence Phenomenon During Cleaning Of Aluminum Container Used For Excipient Fractioning
Favorite
T0930-07-053 - Investigations into Octyldodecanol (Kollicream® OD) Behavior in Skin by Spectroscopic Methods
Favorite
T1430-08-059 - Investigations of Inter-Particle Interactions between API-Excipient for Improvement in Demixing of DPI Formulation
Favorite
W1230-08-059 - Iontophoretic Delivery of Donepezil through Skin Treated by Microneedles and Laser
Favorite
T1530-09-071 - KinetiSol® Dispersing Enables Homogeneous Dispersion of Amorphous API in a Polymeric Carrier
Favorite
T1230-07-049 - Laser Diffraction Analysis of Supersaturated Solutions and Application to Screening of Amorphous Dispersions
Favorite
M1030-12-096 - Laser Head Space Analysis of Oxygen Concentration in a Capsule without Destruction of the Shell
Favorite
W1130-08-064 - Laser-based powder delivery as a versatile transdermal drug delivery platform
Favorite
T1330-08-062 - Leveraging Decreased Non-specific Adhesivity, Receptor-Targeted (DART) Nanoparticles for Treatment of Invasive Brain Tumors
Favorite
M1530-07-051 - Leveraging Surface Plasmon Resonance to Dissect the Interfacial Properties of Nanoparticles for Tumor Penetration
Favorite
T1030-07-054 - Life-time Stability of Size Exclusion Chromatography Columns for Quality Control of Therapeutic Protein Aggregates
Favorite
T1030-08-058 - Lipid Encapsulated Metformin as an Emerging Potential Drug Delivery System for Breast Cancer Treatment
Favorite
M1330-13-104 - Lipid Multiparticulates: A Rapid, Material-Sparing Technology for Early Clinical Development
Favorite
M1330-08-063 - Liposomal Homogenisation Using Microfluidizer® Technology Produces Stable Vesicles with High Entrapment of Amphotericin B
Favorite
M0930-08-061 - Long-Acting Formulations for Intraductal Delivery to the Breast
Favorite
M1330-08-057 - Long-Acting PLGA Microparticles of SNAP, an NO Donor, for a Protracted Reduction of Pulmonary Arterial Pressure in PAH
Favorite
W1030-13-102 - Low Temperature Fused Deposition Modeling (FDM) 3D Printing of Thermolabile Drugs
Favorite
W1130-11-084 - Low-Temperature Selective Laser Sintering 3D Printing of Drug-Loaded Gyroid Lattices
Favorite
T1130-09-070 - L-serine-Modified Polyamidoamine Dendrimer as a Highly Potent Renal Targeting Drug Carrier
Favorite
T1430-08-064 - Lucifer Yellow as a Paracellular Permeability Marker in a Cell Model of the Human BBB for DNA Nanoparticle Delivery.
Favorite
T1130-12-096 - Magnetic Nanoparticle and Field Systems for Treating Oral Caries Biofilms
Favorite
M1030-08-059 - Manufacture and Characterization of Aptamer-Functionalized Nanocarriers for Enhanced Cellular Internalization
Favorite
W0930-11-088 - Manufacture of a Fixed Dose Combination Product for the Treatment of Type II Diabetes by Hot Melt Continuous Granulation
Favorite
T1430-13-099 - Manufacturing of Liposomal Antibiotic Formulations Using High-Throughput Microfluidics Technology
Favorite
T1130-13-103 - Mass Transport Analysis of Bicarbonate Buffer in an In Vitro System, Investigating the Effect of Hydration and Dehydration Reaction Rates of Carbon Dioxide and Carbonic Acid
Favorite
T1530-10-080 - Measurement of the density distributions in ribbons containing paracetamol and various excipients by x-ray µCT and correlation to the minimum solid fraction
Favorite
T1130-13-100 - Measuring Fasted State Gastric Motility Before and After a Standard BA/BE 8oz Drink of Water: Validation of New MRI Imaging Protocols against Concomitant Perfused Manometry in Healthy Participants
Favorite
W1030-10-074 - Mechanical Properties of Polyethylene Oxide Formulated Tablets for Abuse Deterrent Formulations
Favorite
W1230-10-075 - Mechanism to the Reduced Dissolution of Ritonavir by Sodium Lauryl Sulfate
Favorite
T1430-13-097 - Mechanistic Model on pH-Dependent Dissolution of Diclofenac Sodium Extended-Release Tablets
Favorite
T1430-09-071 - Mechanistic Study of Release from Ledipasvir-Copovidone Amorphous Solid Dispersions Using Surface Area Normalized Dissolution
Favorite
M1130-07-055 - Mechanistic Understanding of In Vitro Drug Release of Bupivacaine from Multivesicular Liposomes
Favorite
T1430-12-091 - Mefenamic acid – HPMC AS HG amorphous solid dispersions: Site specific dissolution enhancement using Hot Melt Extrusion Technology
Favorite
M0930-10-078 - Melt Crystallization of Amorphous Pharmaceuticals, from Polymorphism to Physical Stability
Favorite
M1430-09-066 - Melt Crystallization of Griseofulvin/Poly (ethylene oxide) Dispersions: the Enrichment of Polymer at the Crystal-amorphous Interface
Favorite
T1430-13-098 - Melt Processes Used for the Production of Controlled Release Particles
Favorite
W1130-07-049 - Mesoporous Silica Nanoparticles with ROS-Responsive Gatekeepers for MR Imaging-Guided Photodynamic Chemotherapy
Favorite
M1130-12-092 - Metformin Formulation Using Microfluidic Double Emulsions
Favorite
W1230-10-080 - Metformin HCl formulation by continuous direct compression
Favorite
T0930-13-097 - Method Development and Optimization of an In Vitro Permeation Test (IVPT) to Compare the Rate and Extent of Drug Permeation from Topical Drug Products
Favorite
M0930-08-060 - Microbiological Evaluation of Gamma Radiation and Microwave Sterilized Grafts for Periodontological Applications
Favorite
T1330-10-074 - Microemulsion as Potential Ocular Drug Delivery Systems: Phase Diagrams and Physical Properties Depending on Ingredients
Favorite
W1230-08-057 - Microemulsion Formulations for Dermal Delivery of Amitriptyline Free Base
Favorite
T1430-12-095 - Microevaporative dispersion as a predictor of dissolution performance of amorphous dosage forms
Favorite
W1230-07-056 - Microfluidics-based Manufacture of PLGA Nanoparticles and Microparticles for use as Drug Delivery Vehicles.
Favorite
T1230-12-090 - Microscopic imaging and Colorimetric Techniques to Evaluate Surface Characteristics of Degradable 3D Printed Scaffolds for Dermal Regeneration
Favorite
M0930-13-097 - Microstructural Mapping of Dry Powder Inhalers (DPIs) Using Morphologically Directed Raman Spectroscopy (MDRS): A Novel Analytical Tool for DPI Characterization
Favorite
T1230-08-059 - Microwave synthesis of biodegradable poly(β-amino ester) based nanoparticles for ocular delivery
Favorite
W0930-07-050 - Miniaturized Methodology of Polymer Screening for Spray Dried Dispersions
Favorite
T0930-12-095 - Modification of Drug Release Properties of Liposomes by Tricaprin Incorporation
Favorite
T1430-11-083 - Modified Release Coated Soft Gelatin Capsules Dissolution and Physical Stability
Favorite
T1230-11-087 - Modified Release Coated Soft Gelatin Capsules Dissolution Stability
Favorite
T0930-13-102 - Moisture Vapor Transmission Study to Support a Lyophilized Vial Dosage Form
Favorite
M1230-12-096 - Molecular Engineering of Peptide-Modified Gemini Surfactants as Non-Invasive Cutaneous Gene Delivery Vectors
Favorite
M1530-09-066 - Molecular Interaction between Rafoxanide and Povidone for Amorphous Solid Dispersion Preparation
Favorite
T1430-12-090 - Molecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole
Favorite
W0930-10-075 - Molecular Origin of Plasticizing Effects of Lattice Water in Oxalic Acid Crystals
Favorite
T1230-08-062 - MRP1 Efflux Protein Expression Restricts the Penetration of Methotrexate Across the Blood Ocular Barriers: Effect of Specific Inhibitors
Favorite
M1030-08-064 - Mucus-penetrating peptides for improved transport across human cystic fibrotic sputum
Favorite
W1130-07-052 - Multifunctional Nanoparticles as Somatostatin Receptor-Targeting Delivery System of Polyaniline and Methotrexate for Combined Chemo–Photothermal Therapy
Favorite
T1230-12-095 - Multiparticulate drug delivery system for physiologically active proteins and peptides
Favorite
T1030-08-062 - Multi-scale Imaging Using Förster Resonance Energy Transfer for Evaluating Drug Carrier Distribution
Favorite
T1230-09-069 - Nanoclay-Reinforced Osteomimetic Matrices for Bone Tissue Engineering Applications
Favorite
W1030-13-098 - Nano-enabled Fast-Dissolving Orodispersible Films for Buccal Candidiasis
Favorite
M1530-11-088 - Nanoencapsulation of Ferulic Acid to Stabilize in Skin Care Formulations
Favorite
M1330-10-073 - Nanoparticle Formulations Prepared via Flash NanoPrecipitation for Enhanced Bioavailability and Stability
Favorite
T1230-13-099 - Nanoparticulate Neuropeptide Formulations for Sustained Delivery and Brain Targeting
Favorite
W1130-07-055 - Nano-Structured Liquid Crystalline Materials as Infection Responsive Delivery Systems
Favorite
M1130-10-080 - New Workflows for the Evaluation of Solid-forms of Active Pharmaceutical Ingredients in a Formulation
Favorite
M1330-11-087 - Non-Effervescent Floating Tablets of Pregabalin Using Sintering Technique
Favorite
M1530-12-089 - Nonlinear Regression Analysis in Powder Compaction: Application and Identification of Best Fit Models
Favorite
T1030-12-095 - Non-Uniform Drug Distribution Matrix system (NUDDMat) for achievement of zero-order release of drugs with different solubility
Favorite
T0930-10-077 - Novel Approaches for Evaluating and Enhancing Oral Absorption of Peptides
Favorite
W0930-11-087 - Novel Combination Nanodrug Regimen for Synergistic Chemoprevention of Pancreatic Cancer
Favorite
M1030-08-057 - Novel Liquid Anticoagulant Formulation for Oral Delivery in Paediatric Patients and Parenteral Delivery in Emergency Cases; Characterization and Pharmacodynamics Study
Favorite
W0930-07-051 - Novel Method of Disintegration and Breakup for Orally Disintegrating Tablets (ODTs): Simulation of Oral Milieus
Favorite
W1130-09-071 - Novel Microparticulate Vaccine Formulation for the Treatment of Metastatic Breast Cancer
Favorite
T0930-09-065 - Novel Peptide-Enhanced Endostatin-Loaded Nano-Cargo for Targeted Anti-Angiogenesis in Squamous Cell Carcinoma
Favorite
W1130-09-066 - Novel Reverse Vaccination Strategy to Prevent Immunogenicity during Pompe Disease Replacement Therapy
Favorite
W1230-10-078 - Observations of Abuse Deterrent Poly (ethylene oxide) Polymer Tablets Guided by Compression Force and Speed
Favorite
W1230-08-061 - 3-O-ethyl-l-ascorbic Acid: Characterization and Rational Design of Topical Formulations
Favorite
W1030-07-055 - Oleic Acid-Grafted-Chitosan and Thermosensitive Copolymer Based Depot-in-Depot System for Controlled Delivery of Basal Insulin: Effect of Degree of Oleic Acid Substitution
Favorite
W1130-08-058 - Olmesartan Medoxomil Loaded PEGylated bilosomes for Enhanced Transdermal Delivery: In Vitro Characterization, Ex Vivo Permeation and Comprehensive In Vivo Assessment
Favorite
M1430-11-088 - On-Demand and Point-of-Care Printing of Tablets for Sustained Drug Delivery and Personalized Dosing
Favorite
W1030-08-057 - One-Step Self-Assembling Tacrolimus Nanomicelles as a Topical Treatment for Retinal Neovascularization
Favorite
T1230-08-064 - Ophthalmic Formulations Comprising Carboxyvinyl Polymer and Guar-Borate Gelling System Containing Natamycin Loaded PEGylated Nanolipid Carriers: Formulation Optimization, and In vitro Evaluations
Favorite
M1530-13-103 - Ophthalmic Topical Delivery of Carvedilol via Phospholipid Based Cationic Nanocarrier Leciplex
Favorite
W1130-11-083 - OPTICORE™: An Innovative Double-Layer and Two-Triggers Coating Technology to Target the Ileo-Colonic Region
Favorite
W1130-11-082 - OPTICORE™: Clinical Proof-of-Concept of Colonic-Targeted Capsules by Pharmaco-Scintigraphy Study in Healthy Human Subjects
Favorite
T1530-13-103 - OPTICORE™: Effect of an Isolation Layer on Accelerated Drug Release in Conditions Resembling the Ileo-Colonic Region of the Gastrointestinal Tract
Favorite
T1330-07-053 - Optimization and Characterization of In Situ Microparticles of Sucrose Acetate Isobutyrate for Sustained Release of Rivastigmine
Favorite
T1030-08-057 - Optimization of Co-solvent Freeze-Drying Method for the Encapsulation of Thiostrepton in Sterically Stabilized Micelles
Favorite
W0930-12-094 - Optimization of Dermal Flurbiprofen Nanosuspension using Design of Experiment (DoE): Development by Wet Milling
Favorite
M1030-09-070 - Optimization of Ibuprofen Delivery through Rat Skin from Traditional and Novel Nanoemulsion Formulations
Favorite
T1530-13-101 - Optimization of SHetA2 Suspension for the Prevention of Endometrial Cancer
Favorite
M1430-10-076 - Optimization of Sulfobutyl-Ether- β-Cyclodextrin Levels in Oral Formulation to Increase Bioavailability of Progesterone
Favorite
W0930-13-104 - Optimized MSn workflow for improved structure elucidation of pharmaceutically relevant extractables and leachables
Favorite
M1530-12-095 - Optimized Processing Conditions for a Solvent Based Enteric Coating System
Favorite
W1230-09-066 - Optimizing Spray Drying Process Conditions for the Production of a Trehalose/Leucine Formulation with Potential Application in Dry Powder Inhalation
Favorite
M1030-10-077 - Optimizing the Combinations of Polymer and Extrusion Parameters for 3D Printing
Favorite
M1030-08-058 - Oral Delivery of Teriparatide Using a Microemulsion System: Design, Characterization, In Vitro and In Vivo Evaluation
Favorite
W1030-13-104 - Orally Disintegrating Dosage Forms Using Radio Frequency Energy
Favorite
M0930-08-064 - Organogel in situ implants: a promising drug delivery system for therapeutic drugs
Favorite
W1230-13-103 - Orodispersible Films for Personalized Medicine–A Platform and Framework for Its Small-Scale Manufacture at Point-of-Care
Favorite
M1030-11-081 - Osmolyte Stabilized Protein Formulation for Enhanced Wound Healing Activity
Favorite
W1030-07-050 - Osmotic Pump Drug Delivery for Poorly Water-Soluble Drugs Using High Molecular Weight Hydroxyethyl Cellulose as an Osmopolymer
Favorite
W1130-11-081 - Osmotic-Rupturing Multiparticulates: A pH-independent Drug Delivery System Suitable for Delayed or Pulsatile Release Application
Favorite
M0930-13-101 - Over-the-Counter (OTC) Weight Loss Nutraceuticals: Label Claim, Microbiological, Pharmaceutical Quality and Safety Assessments
Favorite
T1430-07-050 - Paclitaxel and Erlotinib-Co-loaded Solid Lipid Core Nanocapsules: Assessment of Physicochemical Characteristics and Cytotoxicity in Non-small Cell Lung Cancer
Favorite
T1530-11-081 - Paclitaxel-Loaded Nano-Liposomes Generated with Consistent Characteristics Using Proliposome Technology Along with High-Pressure Homogenization and Membrane Extrusion
Favorite
M1130-11-087 - Papain and Papain-Cyclodextrin Complex Loaded in Minitablets for Use in Ulcerative Processes and Absorption Enhancer: Complex Characterization and Manufacturing of Minitablets by Direct Compression
Favorite
M1130-08-063 - Paracellular Permeation-Enhancing Effect of Modified Fragments of Tight Junction Modulating Protein
Favorite
T1230-12-096 - Particle Formation of a Freeze-Dried Monoclonal Antibody
Favorite
T1330-13-099 - Passive Inhalation of Dry Powder Influenza Vaccine Formulations: A Feasible Method of Mass Vaccination that Completely Protects Chickens against Lethal Dose of Bird Flu Virus
Favorite
T0930-08-062 - Patient-Specific 3D Scanned and 3D Printed Biomedical Devices
Favorite
T1230-08-060 - Pazopanib Loaded PLGA Nanoparticles for Sustained Drug Delivery to Eye in Diabetic Retinopathy
Favorite
M1430-08-059 - PEG-PLA Polymersomes as Multidrug Nanocarriers for Intranasal Delivery of Therapeutics
Favorite
T1130-09-066 - PEGylated Aspartic Acid Modified Liposome as a Bone-Targeting Carrier for the Delivery of Paclitaxel and Treatment of Bone Metastasis
Favorite
M1330-13-103 - PEGylated Chitosan for Aerosol Delivery of CRISPR/Cas9 System
Favorite
M1330-08-061 - Penetration Ability, Cleansing and Antibacterial Effect of Chlorhexidine Hydrochloride Nanoemulsion as Root Canal Irrigant
Favorite
T1530-08-059 - Percutaneous Absorption and Skin Accumulation of Lorazepam, Diphenhydramine Hydrochloride and Haloperidol from Carbopol Gel
Favorite
M1530-07-049 - Performance Evaluation During Process Development::Different Techniques, Complementary Results
Favorite
W0930-10-080 - Performance of Mini-tablets containing various Lactose-based Excipients.
Favorite
M0930-07-053 - pH and Bicarbonate Molarity Effects on Dissolution of Enteric-Coated Dosage Forms
Favorite
T1030-11-084 - Pharmaceutical Multicomponent System–A New Type of Donepezil-Water-Maleic Acid Crystal and More
Favorite
T1130-12-095 - Pharmacokinetic and tolerability study of a novel 17β-estradiol and progesterone intravaginal ring in sheep
Favorite
W0930-09-072 - Pharmacokinetics and tolerability of a novel progesterone intravaginal ring in sheep
Favorite
M1430-10-077 - Pharmacokinetics Study of Sorafenib Tablet (SYO-1644) with Improved Bioavailability in Beagle Dogs
Favorite
M1330-10-074 - Phase Behavior and Transformation Kinetics of a Poorly Water Soluble Weakly Basic Drug upon Transit from Low to High pH Conditions
Favorite
W1230-11-085 - Photochemically Stabilized Formulation of Dacarbazine with Reduced Production of Algogenic Photodegradants
Favorite
M1030-11-085 - Photo-Induced Tyrosine Side Chain Fragmentation in IgG4-Fc: Mechanisms and Effect of Glycosylation
Favorite
W0930-08-059 - pH-responsive Reversibly Activable Cell-penetrating Peptide-anchored Liposomes for Enhanced Tumor Delivery of Artemisinin
Favorite
M1130-08-061 - pH-Sensitive Nanogels Featuring Reversible Swelling by pH Circulation
Favorite
M0930-11-083 - Physical Properties of Novel Surfactant for Stabilization of Biologics Suggest Mechanism for Improved Performance
Favorite
M1430-07-053 - Physical, Mechanical, and Adhesive Characterization of Soluplus®/Vitamin E Films
Favorite
W1230-10-073 - Physical-Mechanical Evaluation of a Novel Co-processed Tableting Excipient, LubriToseTM Mannitol
Favorite
T0930-08-063 - Physico-chemical and Cell Viability studies of Chitosan/Alginate Microparticles Containing Mycobacterium smegmatis as a Model Mycobacteria Species
Favorite
T1530-08-061 - Physicochemical Properties of a Topical Film Forming Solution Containing Alcoholic Extract of Sahastara Remedy, a Thai Traditional Medicine, for Anti-Inflammation
Favorite
T1330-12-092 - Physiologically relevant in vitro-in vivo correlation (IVIVC) model for the development of sildenafil sustained-release formulation
Favorite
W0930-09-068 - Plateau Hypoxia Attenuates the Metabolic Activity of Intestinal Flora to Lessen the Bioavailability of Clopidogrel
Favorite
M0930-08-062 - Poloxamer-Based Thermosensitive Hydrogel System for Controlled-Release of IKV-741
Favorite
M0930-10-076 - Polymer-Solvent Interactions of Pharmaceutical Excipients for Spray Dried Dispersion
Favorite
M1530-10-074 - Polyvinyl Alcohol (PVA) in Amorphous Solid Dispersions - Understanding the Stabilizing Effect
Favorite
T1330-12-089 - Population pharmacokinetics in vitro-in vivo correalation (IVIVC) approach for the prediction of in vivo pharmacokinetics from formulation composition
Favorite
T1530-12-091 - Potassium Assay in OTC Drug Products by Ion Chromatography
Favorite
T1530-09-070 - Predicting Stability of Ternary Amorphous Solid Dispersion Using Specific Mechanical Energy Input From Hot Melt Extrusion
Favorite
M1530-07-056 - Prediction of Dissolution Profiles from Process Parameters, Formulation, and Spectroscopic Measurements
Favorite
W1130-10-073 - Preferential Drug Loss of Physically Manipulated Abuse-Deterrent (AD) Opioid Drug Products Prepared for Nasal Insufflation Studies
Favorite
W1130-09-068 - Pre-formulation Development of Stabilized Stem Flu Nano-particle Vaccine Candidate
Favorite
M1530-08-061 - Preformulation Studies and Development of Nanoemulgel of Ebselen for the Treatment of Topical Fungal Infection
Favorite
W1030-08-058 - Pregabalin Microemulsion Once Daily Eye Drops for Management of Glaucoma
Favorite
M1130-08-060 - Preparation and Characterization of a Reactive Oxygen Species (ROS)-Triggered Nano Delivery System containing Memantine and Celecoxib
Favorite
T1330-09-072 - Preparation and Characterization of Efavirenz Porous Solid Dispersions Using Pressurized CO2 via Hot Melt Extrusion
Favorite
M1330-08-058 - Preparation and Characterization of Pimozide Loaded Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles for Glioblastoma Targeted Delivery
Favorite
M1530-11-087 - Preparation and Characterization of Ternary Amorphous Solid Dispersion of a Highly Potent and Novel Anti-tubercular Indole-2-Carboxamide Derivative with Curcumin and Hydrophilic Polymers
Favorite
M0930-12-090 - Preparation and Characterization of Ternary Amorphous Solid Dispersions of Reservatrol, Dibenzoylmethane and, Curcumin with Hydrophilic Polymers for Enhancement of Aqueous Solubility and Stability
Favorite
W1230-07-049 - Preparation and Characterization of Various Formulations for Intranasal Delivery of Poorly Soluble Compound Dibenzoylmethane (DBM) for the Treatment of Neurodegenerative Diseases
Favorite
M1430-09-065 - Preparation and Evaluation of Celecoxib Ternary Solid Dispersion Granules Using Solvent Evaporation Based One-Pot Process
Favorite
M1530-13-100 - Preparation and Evaluation of Lipid-Based Formulations for Primaquine Delivery: A Comparison of Solid Lipid Nanoparticles (SLN), Nanostructured Lipid Carriers (NLC), and Nanoemulsions (NE)
Favorite
T1530-10-073 - Preparation and Evaluation of Porous PLGA Microparticles Using Spray Drying Technique
Favorite
T0930-08-060 - Preparation and Evaluation of Valacyclovir Hydrochloride Ocular Inserts Prepared by Hot Melt Extrusion Techniques
Favorite
W1130-08-060 - Preparation and In Vitro Evaluation of Topical Pilocarpine Formulation for Stimulating Sweat Secretion for Cystic Fibrosis Diagnosis: An Alternative to Iontophoresis Technique
Favorite
M0930-12-095 - Preparation and In Vitro Release of Essential Oils Containing Medicated Chewing Gum Formulation for the Treatment of Oral Candidiasis
Favorite
M1330-10-080 - Preparation and lymphatic delivery evaluation of methotrexate-loaded nanoparticles
Favorite
T1330-10-073 - Preparation of Amide Salts Consisting of Acetaminophen and Sulfonic Acids and Its Relative Stability/Tablettability
Favorite
T1430-09-070 - Preparation of Cilostazol Cocrystals with Hydrxybenzoates by Spray Drying Method and Their Characterization
Favorite
T1030-08-061 - Preparation of Curcumin-Resveratrol and Curcumin-Quercetin Nanoparticles for Transdermal Delivery in the Prevention and Treatment of Melanoma
Favorite
M1130-10-074 - Preparation of Dual Targeted Release Formulation Using Hot Melt Extrusion Technology
Favorite
M1030-09-066 - Preparation of Hydrogel Transdermal Patch using Twin Screw Processor
Favorite
M1230-10-075 - Preparation of Itraconazole Amorphous Solid Dispersion and Evaluation In Vitro and Bioavailability In Vivo
Favorite
W1130-07-051 - Preparation of Repaglinide loaded Solid Lipid Nanoparticles by Microfluidization for Oral Delivery of Anti-diabetes Therapeutics
Favorite
M0930-08-058 - 3D-Printed Nanofilms for Sustained Drug Delivery
Favorite
T1230-09-070 - 3D Printed Systems for Colon Specific Drug Delivery Combining Fused Deposition Modelling and Injection Volume Filling
Favorite
M1430-11-085 - 3D Printing of Customizable Zero-Order Release Tablets
Favorite
T1330-11-086 - 3D Printing of Hot-Melt Extruded Clarithromycin Formulations Using Soluplus®︎ and Kolliphor®︎ P407
Favorite
M1230-11-087 - 3D Printing of Orally Disintegrating Tablets
Favorite
M1330-09-065 - Probing the Temperature-Dependence of Structural Relaxation Times Deep in the Glassy State of Amorphous Pharmaceuticals
Favorite
W1230-13-099 - Process and Formulation Effects on Protein Structure and Stability Using Solid State Hydrogen/Deuterium Exchange Mass Spectrometry (ssHDX-MS)
Favorite
M1030-10-076 - Producing Amorphous Solid Dispersions using Electrospraying
Favorite
T1130-09-068 - Protein Corona and Shear Stress Influence the Uptake of Clickable Gelatin-Oleic Nanoparticles for Cancer Targeting
Favorite
W0930-13-101 - Pur Q* Fused Quartz Vials for Enhanced Chemical Stability
Favorite
M1230-13-097 - PVA in Sustained Release Matrix Tablets–Wet Granulated vs Direct Compression
Favorite
W0930-07-053 - Quadrupole Dalton-Based Multiple Attribute Monitoring Method Combined with Rapid Trypsin Digestion for Characterization of Therapeutic Proteins
Favorite
T1130-11-082 - Qualitative Assessment of Silicone Oil and Protein Interactions
Favorite
M1030-12-092 - Quantification of MDMA in Ecstasy Tablets using Near-Infrared Spectroscopy and Partial Least Squares Regression
Favorite
T1030-11-082 - Quantifying Partial Phase Separation of Pharmaceutical Amorphous Solid Dispersions on the 50-nm Scale by Spin Diffusion Solid-State NMR
Favorite
M1230-07-054 - Quantitative Analysis of Peptide-Matrix Interactions in Lyophilized Solids Using Photolytic Labeling
Favorite
W1030-12-091 - Quickly determine protein stability through smart multivariate formulation DoE by assessing Aggregation Rate and Particle Size
Favorite